Preferred Label : analogs and derivatives;

MeSH synonym : analogs & derivatives; derivatives; related compounds;

Details


Main resources

You can consult :


http://www.minerva-ebm.be/FR/Analysis/477
2017
false
false
false
Belgium
French
Dutch
alcoholism
scientific and technical information
treatment outcome
nalmefene
nalmefene
narcotic antagonists
quality of life
meta-analysis as topic
morbidity
alcoholism
naltrexone
naltrexone

---
http://www.has-sante.fr/portail/jcms/c_2746334/fr/depamide
http://www.has-sante.fr/portail/jcms/c_1256028/depamide
http://www.has-sante.fr/portail/jcms/c_486460/fr/depamide
2017
false
France
French
antimanic agents
antimanic agents
manic disorder
treatment outcome
administration, oral
valproic acid
dipropylacetamide
insurance, health, reimbursement
bipolar disorder
adult
dipropylacetamide
pregnancy
teratogens
evaluation of the transparency committee

---
http://ansm.sante.fr/content/download/100793/1278969/version/1/file/DHPC_Prodilantin_Guide-Posologique-Adultes_19-01-2017.pdf
2017
false
false
false
France
French
guidelines for drug use
fosphenytoin
adult
infusions, intravenous
phenytoin
phenytoin
fosphenytoin
status epilepticus
emergency treatment
anticonvulsants

---
http://ansm.sante.fr/content/download/100791/1278955/version/1/file/DHPC_Prodilantin_Guide-Posologique-Enfants_19-01-2017.pdf
2017
false
false
false
France
French
child
infusions, intravenous
anticonvulsants
guidelines for drug use
fosphenytoin
fosphenytoin
phenytoin
phenytoin
emergency treatment
status epilepticus

---
http://asstsas.qc.ca/dossiers-thematiques/fentanyl-et-carfentanil-mesures-preventives-pour-les-techniciens-ambulanciers
2017
false
false
false
false
Canada
French
scientific and technical information
administration, inhalation
carfentanil
fentanyl
analgesics, opioid
occupational exposure
powders
administration, cutaneous
protective clothing
accidents, occupational
accident prevention
poisoning
Accidental fentanyl overdose (disorder)
fentanyl

---
http://www.has-sante.fr/portail/jcms/c_2740895/fr/biocalyptol
2017
false
false
false
France
French
evaluation of the transparency committee
pholcodine
pholcodine
morpholines
codeine
codeine

---
http://www.has-sante.fr/portail/jcms/c_2742062/fr/kardegic
2017
false
false
false
France
French
evaluation of the transparency committee
administration, oral
acetylsalicylic acid
Solusprin, monosalicylate, (DL-Lys)-isomer
acetylsalicylic acid lysinate
aspirin
aspirin
lysine
lysine

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Valproate-et-derives-mise-a-disposition-d-une-carte-patiente-a-remettre-systematiquement-a-votre-patiente-ou-a-son-representant-Lettre-aux-professionnels-de-sante
http://ansm.sante.fr/content/download/101799/1290827/version/1/file/DHPC_Valproate_Carte-Patiente_13-02-2017.pdf
2017
false
false
false
France
French
Divalproex Sodium
pregnancy
valproate sodium
valproic acid
valpromide
dipropylacetamide
anticonvulsants
abnormalities, drug-induced
prenatal exposure delayed effects
continuity of patient care
contraception
adult
adolescent
women
maternal exposure
guidelines for drug use
patient education handout
-
risk reduction behavior
product surveillance, postmarketing
valproic acid
valproic acid

---
http://www.has-sante.fr/portail/jcms/c_2746198/fr/prostatep
2017
false
false
false
France
French
drug information
injections, intravenous
radiopharmaceuticals
prostatic neoplasms
carcinoma, hepatocellular
Positron-Emission tomography
fluoromethylcholine (18F)
fluorine radioisotopes
fluorocholine
insurance, health, reimbursement
neoplasm metastasis
adult
neoplasm recurrence, local
neoplasm staging
choline
choline

---
http://www.has-sante.fr/portail/jcms/c_2746192/fr/revlimid-myelome-multiple
http://www.has-sante.fr/portail/jcms/c_2746192/fr/revlimid-lenalidomide-immunosuppresseur-myelome-multiple
2017
false
false
false
false
France
French
administration, oral
adult
antineoplastic combined chemotherapy protocols
survival analysis
treatment outcome
lenalidomide
lenalidomide
teratogens
lenalidomide
evaluation of the transparency committee
guidelines for drug use
immunosuppressive agents
immunosuppressive agents
orphan drug production
continuity of patient care
risk management
pregnancy
dexamethasone
multiple myeloma
thalidomide
thalidomide
thalidomide

---
http://www.has-sante.fr/portail/jcms/c_2746930/fr/metvixia
http://www.has-sante.fr/portail/jcms/c_2746930/fr/metvixia-aminolevulinate-de-methyle-therapie-photodynamique
2017
false
false
France
French
English
facial dermatoses
scalp dermatoses
sunlight
guidelines for drug use
methyl 5-aminolevulinate
aminolevulinic acid
photosensitizing agents
insurance, health, reimbursement
methyl aminolevulinate
administration, cutaneous
keratosis, actinic
adult
aged
treatment outcome
evaluation of the transparency committee

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Valproate-et-derives-renforcement-de-l-information-sur-les-risques-Point-d-Information
2017
false
false
false
France
French
Divalproex Sodium
pregnancy
valproate sodium
valproic acid
valpromide
dipropylacetamide
anticonvulsants
abnormalities, drug-induced
prenatal exposure delayed effects
contraception
adult
adolescent
women
maternal exposure
legislation, pharmacy
-
harm reduction
drug information
valproic acid
valproic acid

---
http://gpip.sfpediatrie.com/actualite/p%C3%A9nurie-de-c%C3%A9fixime-recommandations-gpipsfp-sur-la-strat%C3%A9gie-th%C3%A9rapeutique-du-traitement
2017
false
false
false
France
French
practice guideline
child
urinary tract infections
cystitis
anti-bacterial agents
cefixime
administration, oral
Trimethoprim, Sulfamethoxazole Drug Combination
cefpodoxime proxetil
microbial sensitivity tests
cefixime
ceftizoxime
ceftizoxime

---
http://www.has-sante.fr/portail/jcms/c_2749479/fr/relistor
2017
false
false
false
France
French
evaluation of the transparency committee
naltrexone methylbromide
methylnaltrexone bromide
opioid induced constipation
methylnaltrexone
quaternary ammonium compounds
naltrexone
naltrexone

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Rappel-sur-l-utilisation-des-collyres-mydriatiques-en-pediatrie-Point-d-information
2017
false
false
false
France
French
guidelines for drug use
child
mydriatics
administration, ophthalmic
ophthalmic solutions
infant, premature
infant, newborn
infant
atropine
atropine
phenylephrine
pharmacovigilance note
anticholinergics
phenylephrine

---
http://www.has-sante.fr/portail/jcms/c_2740913/fr/secnol
2017
false
false
France
French
vaginosis, bacterial
secnidazole
secnidazole
treatment outcome
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
secnidazole
metronidazole
metronidazole
metronidazole

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004140/human_med_002038.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
edotreotide
drug approval
treatment outcome
europe
radiopharmaceuticals
gastro-enteropancreatic neuroendocrine tumor
Positron-Emission tomography
adult
orphan drug production
injections, intravenous
gallium radioisotopes
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
gallium (68Ga) edotreotide
drug evaluation, preclinical
edotreotide
octreotide
intestinal neoplasms
pancreatic neoplasms
stomach neoplasms
neuroendocrine tumors

---
http://www.has-sante.fr/portail/jcms/c_2751879/fr/revlimid-lcm
https://www.has-sante.fr/portail/jcms/c_2751879/fr/revlimid-lenalidomide-immunosuppresseur
2017
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
administration, oral
antineoplastic agents
lenalidomide
lenalidomide
lymphoma, mantle-cell
Refractory Mantle Cell Lymphoma
Recurrent Mantle Cell Lymphoma
recurrence
adult
Progression-Free survival
guidelines for drug use
disease-free survival
thalidomide
thalidomide

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004169/human_med_002061.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
tenofovir alafenamide
GS-7340
antiviral agents
antiviral agents
drug approval
europe
treatment outcome
tenofovir alafenamide
adult
adolescent
hepatitis B, chronic
administration, oral
reverse transcriptase inhibitors
reverse transcriptase inhibitors
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
tenofovir alafenamide
GS-7340
adenine

---
http://www.has-sante.fr/portail/jcms/c_2752839/fr/daivonex
2017
false
false
false
France
French
evaluation of the transparency committee
administration, cutaneous
insurance, health, reimbursement
treatment outcome
calcipotriol
calcipotriene
calcitriol
calcitriol

---
http://ansm.sante.fr/S-informer/Travaux-de-l-Agence-Europeenne-des-Medicaments-EMA-Comite-pour-l-evaluation-des-risques-en-matiere-de-pharmacovigilance-PRAC/Selexipag-Uptravi-docetaxel-produits-de-contraste-contenant-du-gadolinium-retour-d-information-sur-le-PRAC-d-avril-2017-Point-d-Information
2017
false
false
false
France
French
drug information
drug evaluation
risk assessment
administration, oral
hypertension, pulmonary
selexipag
pharmacovigilance
docetaxel
organometallic compounds
gadolinium
gadolinium DTPA
gadolinium
contrast media
acetamides
pyrazines
taxoids

---
Iodinated Contrast Media - Potential Risk of Hypothyroidism
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2017/63086a-fra.php
2017
false
false
false
French
English
pharmacovigilance note
contrast media
hypothyroidism
risk
infant
infant, newborn
infant, premature
x-ray contrast media, iodinated
Iodinated Contrast Agent
iodine

---
http://www.has-sante.fr/portail/jcms/c_2015058/fr/quelle-place-pour-les-benzodiazepines-dans-l-insomnie
2017
false
false
false
France
French
sleep initiation and maintenance disorders
benzodiazepines
estazolam
benzodiazepine derivatives
benzodiazepines
drug prescriptions
triazulenone
lormetazepam
nitrazepam
temazepam
zolpidem
benzodiazepine related drugs
zopiclone
hypnotics and sedatives
guidelines for drug use
adult
aged
piperazines
azabicyclo compounds
lorazepam
lorazepam
pyridines

---
http://www.has-sante.fr/portail/jcms/c_2757143/fr/firdapse
2017
false
false
France
French
administration, oral
3,4-diaminopyridine
potassium channel blockers
treatment outcome
4-Aminopyridine
3,4-diaminopyridine
insurance, health, reimbursement
amifampridine
adult
lambert-eaton myasthenic syndrome
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2757888/fr/onivyde
https://www.has-sante.fr/portail/jcms/c_2757888/fr/onivyde-irinotecan-liposomal-pegyle-antineoplasique
2017
false
false
false
France
French
treatment outcome
irinotecan
irinotecan
adult
neoplasm metastasis
pancreatic neoplasms
adenocarcinoma
Metastatic Pancreatic Adenocarcinoma
antineoplastic combined chemotherapy protocols
antineoplastic agents, phytogenic
antineoplastic agents, phytogenic
infusions, intravenous
topoisomerase I inhibitors
topoisomerase I inhibitors
evaluation of the transparency committee
fluorouracil
leucovorin
disease progression
survival analysis
Pegylated Liposomal Irinotecan
guidelines for drug use
irinotecan
camptothecin

---
http://www.centreantipoisons.be/professionnels-de-la-sant/articles-pour-les-v-t-rinaires/intoxication-aux-antilimaces-base-de-m-tald
2017
false
false
false
Belgium
French
scientific and technical information
molluscacides
Molluscicide causing toxic effect (disorder)
animals
metaldehyde
acetaldehyde

---
http://www.omedit-normandie.fr/media-files/6996/guide-imid-v200417-v2.pdf
2017
false
false
false
France
French
guideline
patient safety
pharmacy service, hospital
ambulatory care
thalidomide
drug prescriptions
lenalidomide
pomalidomide
risk management
teratogens
pregnancy
multiple myeloma
immunologic factors
immunologic factors
immunologic factors
thalidomide
lenalidomide
pomalidomide
thalidomide

---
http://www.has-sante.fr/portail/jcms/c_2751867/fr/vectibix
2017
false
France
French
IFL protocol
Metastatic colorectal cancer
evaluation of the transparency committee
panitumumab
panitumumab
infusions, intravenous
panitumumab
antineoplastic combined chemotherapy protocols
colorectal neoplasms
neoplasm metastasis
KRAS protein, human
colorectal neoplasms
antineoplastic agents
antineoplastic agents
receptor, epidermal growth factor
genetic testing
treatment outcome
survival analysis
proto-oncogene proteins
ras proteins
antibodies, monoclonal
antibodies, monoclonal
Proto-Oncogene proteins p21(ras)
antineoplastic combined chemotherapy protocols
camptothecin
camptothecin
leucovorin
fluorouracil

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Levetiracetam-100-mg-ml-solution-buvable-Keppra-et-generiques-erreurs-medicamenteuses-liees-aux-seringues-doseuses-ayant-entraine-un-surdosage-Lettre-aux-professionnels-de-sante
2017
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
medication errors
anticonvulsants
levetiracetam
levetiracetam
levetiracetam
Drug overdose accidental
administration, oral
pharmaceutical solutions
infant
child
adolescent
adult
epilepsy
etiracetam
etiracetam
piracetam
piracetam
piracetam

---
https://www.revmed.ch/RMS/2016/RMS-N-520/Double-antiagregation-plaquettaire-pour-le-traitement-et-la-prevention-secondaire-de-la-maladie-coronarienne-Indications-modalites-et-durees-de-traitement
2017
false
false
false
Switzerland
French
journal article
secondary prevention
platelet aggregation inhibitors
coronary disease
coronary disease
Duration of treatment (qualifier value)
hemorrhage
platelet aggregation inhibitors
review of literature
drug therapy, combination
clopidogrel
aspirin
administration, oral
treatment outcome
Prasugrel Hydrochloride
ticagrelor
ischemia
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
purinergic P2Y12 receptor antagonists
purinergic P2Y12 receptor antagonists
percutaneous coronary intervention
acute coronary syndrome
practice guidelines as topic
ticlopidine
ticlopidine
adenosine
adenosine

---
https://www.has-sante.fr/portail/jcms/c_2770187/fr/imbruvica-lcm
2017
false
false
false
false
France
French
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
treatment outcome
ibrutinib
ibrutinib
orphan drug production
ibrutinib
adult
Recurrent Mantle Cell Lymphoma
Refractory Mantle Cell Lymphoma
lymphoma, mantle-cell
IBtk protein, human
protein-tyrosine kinases
protein kinase inhibitors
protein kinase inhibitors
survival analysis
comparative effectiveness research
temsirolimus
PCI 32765
PCI 32765
carrier proteins
pyrazoles
pyrimidines
pyrazoles
pyrimidines
sirolimus
sirolimus

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Fluindione-Previscan-R-mises-en-garde-sur-le-risque-d-effets-indesirables-immuno-allergiques-Lettre-aux-professionnels-de-sante
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Previscan-fluindione-et-risque-immuno-allergique-Point-d-Information
2017
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
administration, oral
fluindione
continuity of patient care
fluindione
france
vitamin K
antivitamins K
anticoagulants
drug hypersensitivity
kidney function tests
liver function tests
hematologic tests
skin manifestations
phenindione
phenindione
indenes
4-hydroxycoumarins

---
https://www.has-sante.fr/portail/jcms/c_2773278/fr/ocaliva
https://www.has-sante.fr/portail/jcms/c_2773278/fr/ocaliva-acide-obeticholique-acide-biliaire
2017
false
false
false
France
French
treatment outcome
orphan drug production
cholangitis
Primary cholangitis (disorder)
obeticholic acid
obeticholic acid
adult
drug therapy, combination
ursodeoxycholic acid
administration, oral
evaluation of the transparency committee
guidelines for drug use
chenodeoxycholic acid
chenodeoxycholic acid

---
https://www.has-sante.fr/portail/jcms/c_2774120/fr/descovy
2017
false
false
false
France
French
drug combinations
treatment outcome
emtricitabine and tenofovir alafenamide
anti-hiv agents
hiv infections
HIV-1
human immunodeficiency virus i infection
drug therapy, combination
administration, oral
reverse transcriptase inhibitors
adult
adolescent
emtricitabine tenofovir alafenamide
evaluation of the transparency committee
insurance, health, reimbursement
Emtricitabine
Tenofovir
adenine

---
https://www.has-sante.fr/portail/jcms/c_2775799/fr/viekirax-exviera
2017
false
false
false
false
France
French
evaluation of the transparency committee
drug combinations
administration, oral
hepatitis C, chronic
drug therapy, combination
adult
anilides
carbamates
antiviral agents
macrocyclic compounds
ritonavir
sulfonamides
uracil
treatment outcome
insurance, health, reimbursement
Hepatitis C virus genotype 1 (organism)
ombitasvir
dasabuvir
paritaprevir
other antivirals
ABT-267
ABT-333
ABT-450

---
Topiramate for pediatric migraine prevention
http://www.cfp.ca/content/63/7/532
2017
false
false
false
Canada
French
English
journal article
child
migraine disorders
topiramate
treatment outcome
randomized controlled trials as topic
comparative effectiveness research
canada
topiramate
Drugs used in migraine prophylaxis (product)
migraine prophylaxis
chemoprevention
fructose
fructose
fructose

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Depakote-et-Depamide-dans-les-troubles-bipolaires-desormais-contre-indiques-chez-les-femmes-enceintes-et-chez-les-femmes-en-age-de-procreer-n-utilisant-pas-une-contraception-efficace-Lettre-aux-professionnels-de-sante
2017
false
false
false
France
French
Divalproex Sodium
guidelines for drug use
dipropylacetamide
antimanic agents
drug prescriptions
bipolar disorder
contraception
pregnancy
Female of child bearing age (finding)
informed consent
pregnancy tests
valpromide
valproic acid
pharmacovigilance note
valproic acid
valproic acid

---
http://ansm.sante.fr/content/download/77297/980487/version/3/file/DEPAKOTE_DEPAMIDE_GUIDE_PS-2017.pdf
2017
false
false
false
France
French
Divalproex Sodium
guidelines for drug use
dipropylacetamide
drug prescriptions
bipolar disorder
contraception
pregnancy
Female of child bearing age (finding)
informed consent
pregnancy tests
valpromide
valproic acid
pharmacovigilance note
dipropylacetamide
Divalproex Sodium
dipropylacetamide
Divalproex Sodium
risk
prenatal exposure delayed effects
antimanic agents
adult
valproic acid
valproic acid
valproic acid
valproic acid

---
http://www.cochrane.org/fr/CD011412/traitement-de-lepilepsie-avec-un-seul-medicament-antiepileptique-monotherapie
2017
false
false
false
France
French
french abstract
seizures
review of literature
epilepsies, partial
anticonvulsants
carbamazepine
phenytoin
comparative effectiveness research
valproic acid
valproate sodium
gabapentin
oxcarbazepine
topiramate
lamotrigine
etiracetam
levetiracetam
zonisamide
antiepileptics
amines
cyclohexanecarboxylic acids
gamma-aminobutyric acid
carbamazepine
fructose
fructose
triazines
piracetam
piracetam
isoxazoles

---
https://www.has-sante.fr/portail/jcms/c_2788656/fr/somakit-toc
2017
false
false
false
France
French
edotreotide
radiopharmaceuticals
gastro-enteropancreatic neuroendocrine tumor
Positron-Emission tomography
adult
orphan drug production
injections, intravenous
gallium radioisotopes
aged
gallium (68Ga) edotreotide
evaluation of the transparency committee
receptors, somatostatin
neoplasm metastasis
Gallium Ga 68-Edotreotide
edotreotide
octreotide
intestinal neoplasms
pancreatic neoplasms
stomach neoplasms
neuroendocrine tumors

---
http://circulaire.legifrance.gouv.fr/index.php?action=afficherCirculaire&hit=1&r=42484
http://circulaire.legifrance.gouv.fr/pdf/2017/08/cir_42484.pdf
2017
false
false
false
France
French
legislation
insurance, health, reimbursement
hepatitis C, chronic
elbasvir-grazoprevir drug combination
dasabuvir
legislation, drug
antiviral agents
ritonavir
Oral form ombitasvir + paritaprevir + ritonavir (product)
ombitasvir
paritaprevir
direct acting antivirals
daclatasvir
administration, oral
Simeprevir
sofosbuvir-velpatasvir drug combination
ledipasvir, sofosbuvir drug combination
Multidisciplinary care conference (procedure)
Interdisciplinary medical team conference (procedure)
ABT-333
ABT-267
ABT-450
BMS-790052
benzofurans
drug combinations
imidazoles
quinoxalines
Sofosbuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
sulfonamides
uracil
uracil
anilides
macrocyclic compounds

---
Oxervate cenegermin
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004209/human_med_002135.jsp&mid=WC0b01ac058001d124
2017
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
nerve growth factor
orphan drug production
Neurotrophic keratopathy
keratitis
adult
ophthalmic solutions
administration, ophthalmic
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
recombinant proteins
recombinant proteins

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Dacogen-R-50-mg-poudre-pour-solution-a-diluer-pour-perfusion-changement-des-recommandations-pour-la-dilution-de-la-solution-reconstituee-de-Dacogen-R-Lettre-aux-professionnels-de-sante
2017
false
false
false
France
French
pharmacovigilance note
drug compounding
Dilution (qualifier value)
guideline
decitabine
decitabine
infusions, intravenous
powders
drug compounding
azacitidine
azacitidine

---
http://www.minerva-ebm.be/FR/Article/2125
2017
false
false
false
Belgium
French
Dutch
critical appraisal or critical reading
child
adolescent
migraine disorders
amitriptyline
placebos
topiramate
treatment outcome
amitriptyline
topiramate
Evidence-Based medicine
headache disorders
fructose
fructose
fructose

---
http://lemedecinduquebec.org/archives/2017/9/4-l-hypercalcemie-comment-s-y-retrouver-docteur/
2017
false
false
false
Canada
French
journal article
hypercalcemia
hypercalcemia
hypercalcemia
chronic disease
parathyroid hormone
hypercalcemia
hypocalciuric hypercalcemia, familial, type 1
hyperparathyroidism, primary
multiple myeloma
bone neoplasms
neoplasm metastasis
Bone metastasis
algorithms
diagnosis, differential
parathyroid hormone-related protein
1, 25-Dihydroxyvitamin D Measurement
1,25-dihydroxyvitamin D
25-Hydroxyvitamin D Measurement
25-hydroxyvitamin D
hypercalcemia
vitamin D
vitamin D

---
http://lemedecinduquebec.org/archives/2017/10/4-les-petits-signes-sur-les-ongles-qui-en-disent-long/
2017
false
false
false
Canada
French
journal article
dystrophia unguium
nail diseases
nail diseases
nail diseases
diagnosis, differential
onychomycosis
risk factors
onycholysis
psoriasis
Psoriatic nail dystrophy (disorder)
nail psoriasis
calcipotriene
glucocorticoids
Melanonychia
Traumatic onycholysis (disorder)
onychogryphosis
onychomadesis
Median nail dystrophy of Heller (disorder)
Onychoschizia
Onychorrhexis
Subungual haematoma
melanoma
signs and symptoms
neoplasms, adnexal and skin appendage
Malignant melanoma of nail apparatus (disorder)
calcitriol
calcitriol

---
https://www.has-sante.fr/portail/jcms/c_2779830/fr/ninlaro
2017
false
false
false
France
French
treatment outcome
ixazomib
ixazomib
ixazomib
orphan drug production
adult
multiple myeloma
antineoplastic combined chemotherapy protocols
antineoplastic agents
antineoplastic agents
administration, oral
proteasome inhibitors
proteasome inhibitors
dexamethasone
lenalidomide
survival analysis
aged
evaluation of the transparency committee
boron compounds
glycine
boron compounds
thalidomide
thalidomide

---
https://www.has-sante.fr/portail/jcms/c_2796803/fr/xenetix
2017
false
false
false
France
French
evaluation of the transparency committee
iobitridol
contrast media
xenetix
iobitridol
iohexol

---
https://www.has-sante.fr/portail/jcms/c_2796806/fr/vitamine-a-nepalm
2017
true
France
French
evaluation of the transparency committee
vitamins
retinol palmitate
injections, intramuscular
vitamin a deficiency
vitamin A
retinol (vit a)
insurance, health, reimbursement
treatment outcome

---
https://www.has-sante.fr/portail/jcms/c_2797158/fr/epitomax
2017
true
France
French
Lennox Gastaut Syndrome
seizures
seizures, Tonic-Clonic
adolescent
topiramate
administration, oral
anticonvulsants
topiramate
insurance, health, reimbursement
adult
child
migraine disorders
epilepsies, partial
fructose
evaluation of the transparency committee

---
N1-VALIDE
https://www.has-sante.fr/portail/jcms/c_2779827/fr/estrotep-fluoroestradiol-18f-radiopharmaceutique-a-usage-diagnostique
https://www.has-sante.fr/portail/jcms/c_2779827/fr/estrotep
2017
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
radiopharmaceuticals
18-fluoro-17-estradiol
18-fluoro-17-estradiol
fluoroestradiol (18F)
breast neoplasms
neoplasm metastasis
Positron-Emission tomography
adult
neoplasms, hormone-dependent
Oestrogen receptor positive breast cancer
injections, intravenous

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Prodilantin-75-mg-ml-fosphenytoine-sodique-Erreurs-medicamenteuses-pouvant-etre-d-issue-fatale-en-particulier-chez-les-enfants-ages-de-moins-de-5-ans-utilisation-hors-AMM-Lettre-aux-professionnels-de-sante
2017
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
child
medication errors
fosphenytoin
fosphenytoin
heart arrest
prodrugs
Phenytoin Sodium
fosphenytoin
Off-Label use
drug overdose
status epilepticus
infant
phenytoin
phenytoin
phenytoin

---
http://www.has-sante.fr/portail/jcms/c_2658522/fr/prexidine
http://www.has-sante.fr/portail/jcms/c_928157/prexidine
2016
false
France
French
Oral infection (disorder)
oral surgical procedures
postoperative care
chlorhexidine gluconate
mouthwashes
chlorhexidine
chlorhexidine
anti-infective agents, local
adult
child
adolescent
treatment outcome
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2679446/fr/neo-codion-adultes
http://www.has-sante.fr/portail/jcms/c_1146528/neo-codion-adulte
http://www.has-sante.fr/portail/jcms/c_456399/fr/neo-codion
2016
false
France
French
cough
dry cough
codeine
codeine
antitussive agents
pharmaceutical solutions
adult
administration, oral
codeine
antitussive agents
codeine
insurance, health, reimbursement
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2631819/fr/frakidex
http://www.has-sante.fr/portail/jcms/c_1046769/frakidex
http://www.has-sante.fr/portail/jcms/c_455418/fr/frakidex
2016
false
France
French
adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
antibiotic therapy
postoperative care
drug combinations
dexamethasone
dexamethasone 21-phosphate
framycetin
anti-bacterial agents
glucocorticoids
dexamethasone and antiinfectives
eye infections, bacterial
insurance, health, reimbursement
ophthalmic solutions
dexamethasone sodium phosphate
Neomycin B Sulfate
administration, ophthalmic
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2627645/fr/activelle-kliogest-novofemme-trisequens
http://www.has-sante.fr/portail/jcms/c_1048378/activelle-kliogest-novofemme-trisequens
http://www.has-sante.fr/portail/jcms/c_544823/fr/activelle-/-kliogest-/-novofemme-/-trisequens
2016
false
France
French
Trisequens
progesterone congeners
estradiol, norethindrone drug combination
administration, oral
drug combinations
norethindrone acetate
norethindrone
estradiol
norethisterone and estrogen
estrogens
norethisterone and estrogen
insurance, health, reimbursement
estrogen replacement therapy
osteoporosis, postmenopausal
treatment outcome
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2678844/fr/dicodin-lp
http://www.has-sante.fr/portail/jcms/c_1172434/dicodin
http://www.has-sante.fr/portail/jcms/c_477434/fr/dicodin
2016
false
France
French
treatment outcome
pain
moderate pain
dihydrocodeine
administration, oral
Delayed-Action preparations
analgesics, opioid
insurance, health, reimbursement
dihydrocodeine
codeine
tablets
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2598656/fr/trileptal
http://www.has-sante.fr/portail/jcms/c_1098678/trileptal
http://www.has-sante.fr/portail/jcms/c_456631/fr/trileptal
2016
false
France
French
adolescent
oxcarbazepine
adult
child
epilepsies, partial
drug therapy, combination
oxcarbazepine
carbamazepine
anticonvulsants
pharmaceutical solutions
administration, oral
insurance, health, reimbursement
tablets
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2630754/fr/logimax
http://www.has-sante.fr/portail/jcms/c_1046799/logimax
http://www.has-sante.fr/portail/jcms/c_399332/fr/logimax-5-mg/47-5mg-comprime-pellicule-a-liberation-prolongee-boite-de-28
2016
false
France
French
metoprolol succinate
treatment outcome
Delayed-Action preparations
administration, oral
drug combinations
antihypertensive agents
felodipine
calcium channel blockers
metoprolol and felodipine
insurance, health, reimbursement
hypertension
metoprolol
tablets
adrenergic beta-1 receptor antagonists
evaluation of the transparency committee
metoprolol

---
http://www.has-sante.fr/portail/jcms/c_2588386/fr/orelox
http://www.has-sante.fr/portail/jcms/c_1019636/orelox
2016
false
France
French
pharyngitis
streptococcal infections
otitis media
sinusitis
exacerbation of chronic obstructive bronchitis
pulmonary disease, chronic obstructive
pneumonia, bacterial
bronchitis
antibiotic therapy
cefpodoxime proxetil
adult
child
administration, oral
ceftizoxime
anti-bacterial agents
infant
insurance, health, reimbursement
cefpodoxime
treatment outcome
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2587895/fr/zinnat
http://www.has-sante.fr/portail/jcms/c_1019665/zinnat
2016
false
France
French
antibiotic therapy
cefuroxime axetil
anti-bacterial agents
administration, oral
injections, intramuscular
adult
child
infant
cefuroxime
insurance, health, reimbursement
cefuroxime
treatment outcome
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2642053/fr/tiorfan-tiorfanor
http://www.has-sante.fr/portail/jcms/c_951425/tiorfan-tiorfanor
2016
false
false
France
French
diarrhea
acute diarrhea
diarrhea, infantile
racecadotril
administration, oral
racecadotril
antidiarrheals
thiorphan
adult
protease inhibitors
neprilysin
insurance, health, reimbursement
infant
child
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2637984/fr/diaseptyl
http://www.has-sante.fr/portail/jcms/c_1036272/diaseptyl
2016
false
France
French
antisepsis
treatment outcome
administration, cutaneous
chlorhexidine gluconate
chlorhexidine
chlorhexidine
anti-infective agents, local
insurance, health, reimbursement
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2610158/fr/plavix
http://www.has-sante.fr/portail/jcms/c_2610158/fr/plavix-clopidogrel-antiagregant-plaquettaire
2016
false
France
French
guidelines for drug use
drug therapy, combination
aspirin
thromboembolism
atrial fibrillation
insurance, health, reimbursement
thrombosis
atherosclerosis
clopidogrel
platelet aggregation inhibitors
administration, oral
clopidogrel
ticlopidine
clopidogrel bisulfate
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2617883/fr/paroex
http://www.has-sante.fr/portail/jcms/c_1036552/paroex
2016
false
France
French
postoperative care
oral surgical procedures
mouth diseases
chlorhexidine
chlorhexidine gluconate
anti-infective agents, local
insurance, health, reimbursement
administration, buccal
chlorhexidine
mouthwashes
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2637987/fr/locoid
http://www.has-sante.fr/portail/jcms/c_1072222/locoid
http://www.has-sante.fr/portail/jcms/c_523285/locoid
2016
false
France
French
corticosteroid therapy
evaluation of the transparency committee
hydrocortisone-17-butyrate
hydrocortisone
hydrocortisone butyrate
dermatologic agents
administration, topical
anti-inflammatory agents
insurance, health, reimbursement

---
http://www.has-sante.fr/portail/jcms/c_2679263/fr/modecate
http://www.has-sante.fr/portail/jcms/c_1241695/modecate
2016
false
France
French
evaluation of the transparency committee
treatment outcome
fluphenazine depot
fluphenazine
injections, intramuscular
Delayed-Action preparations
antipsychotic agents
fluphenazine
insurance, health, reimbursement
chronic disease
schizophrenia
paranoid disorders
psychotic disorders
schizophrenia, paranoid

---
http://www.has-sante.fr/portail/jcms/c_2621279/fr/navelbine
http://www.has-sante.fr/portail/jcms/c_1260369/navelbine
http://www.has-sante.fr/portail/display.jsp?id=c_247485
2016
false
France
French
Stage IV Breast Cancer
antineoplastic agents, phytogenic
administration, oral
breast neoplasms
neoplasm metastasis
vinblastine
vinorelbine
vinorelbine
vinorelbine tartrate
carcinoma, non-small-cell lung
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
treatment outcome
clinical trials, phase ii as topic
evaluation of the transparency committee

---
http://www.afef.asso.fr/ckfinder/userfiles/files/recommandations-textes-officiels/Recommandations_AFEF_HepatiteC_Final-02-2016.pdf
http://www.infectiologie.com/UserFiles/File/medias/Recos/2015-juin-Recommandations-AFEF-Hepatite-C.pdf
2016
false
false
true
false
France
French
hepatitis C, chronic
practice guideline
severity of illness index
hepatitis C, chronic
antiviral agents
comorbidity
genotype
daclatasvir
ledipasvir
ribavirin
treatment outcome
drug resistance, viral
pregnancy
patient education as topic
liver cirrhosis
liver transplantation
recurrence
renal insufficiency
child
adolescent
drug users
hiv infections
acute disease
Acute hepatitis C
Simeprevir
Sofosbuvir
ledipasvir
ledipasvir, sofosbuvir drug combination
BMS-790052
imidazoles
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate

---
CellCept (mycophenolate mofetil) and MYFORTIC (mycophenolate sodium) - Serious Risk of Teratogenicity in Mycophenolate-Containing Products
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2016/56690a-fra.php
2016
false
false
false
Canada
French
English
pregnancy
pharmacovigilance note
abnormalities, drug-induced
immunosuppressive agents
risk
teratogens
abortion, spontaneous
infant, newborn
breast feeding
contraception
graft rejection
mycophenolic acid
mycophenolic acid

---
https://www.anses.fr/fr/content/avis-de-l%E2%80%99anses-sur-le-caract%C3%A8re-canc%C3%A9rog%C3%A8ne-pour-l%E2%80%99homme-du-glyphosate
https://www.anses.fr/fr/system/files/SUBCHIM2015sa0093.pdf
2016
false
false
false
France
French
consensus
glyphosate
carcinogens, environmental
herbicides
glycine
glycine

---
http://www.has-sante.fr/portail/jcms/c_2608656/fr/hydrocortisone-biocodex
2016
false
true
false
false
France
French
evaluation of the transparency committee
adrenal hyperplasia, congenital
injections, intravenous
injections, intramuscular
hydrocortisone
adrenal insufficiency
acute disease
hydrocortisone
treatment outcome
infant, newborn
adult
insurance, health, reimbursement
hydrocortisone

---
http://www.has-sante.fr/portail/jcms/c_2609229/fr/apidra
2016
true
France
French
diabetes mellitus
insulin glulisine
hypoglycemic agents
insulin glulisine
insurance, health, reimbursement
adult
adolescent
child
injections, subcutaneous
insulin, Short-Acting
insulin
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2610191/fr/cefuroxime-bgr
2016
false
false
false
France
French
evaluation of the transparency committee
cefuroxime
Cefuroxime axetil 500mg tablet (product)
drugs, generic
administration, oral
cefuroxime axetil
anti-bacterial agents
insurance, health, reimbursement
cefuroxime

---
Summary Basis of Decision (SBD) for Eperzan
Albiglutide 30 mg/0.5 mL and 50 mg/0.5 mL, powder for solution, subcutaneous
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00285
2016
false
false
false
false
Canada
French
English
rGLP-1 protein
rGLP-1 protein
injections, subcutaneous
drug approval
canada
summary of product characteristics
treatment outcome
diabetes mellitus, type 2
adult
incretins
incretins
drug therapy, combination
drug evaluation
risk assessment
pregnancy
breast feeding
albiglutide
glucagon-like peptide 1
glucagon-like peptide 1
glucagon-like peptide 1

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-immunomodulateurs-IMID-Thalidomide-Lenalidomide-Pomalidomide-Anticancereux-par-voie-orale-informer-prevenir-et-gerer-leurs-effets-indesirables
2016
false
false
false
France
French
thalidomide
Drug-Related side effects and adverse reactions
antineoplastic combined chemotherapy protocols
thalidomide
Drug-Related side effects and adverse reactions
administration, oral
antineoplastic agents
immunologic factors
lenalidomide
lenalidomide
drug interactions
practice guideline
pomalidomide
pomalidomide
information dissemination
continuity of patient care
pregnancy
patient education as topic
thalidomide

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Mycophenolate-mofetil-CellCept-R-et-generiques-et-mycophenolate-sodique-Myfortic-R-risque-important-de-teratogenicite-Diffusion-d-un-materiel-educationnel-et-modification-des-conditions-de-prescription-et-delivrance-Lettre-aux-professionnels-de-sante
2016
false
false
false
France
French
pharmacovigilance note
teratogens
drugs, generic
mycophenolic acid
Mycophenolate Sodium
legislation, drug
drug prescriptions
patient education as topic
guidelines for drug use
pregnancy
risk management
patients guideline
risk
contraception
forms
Mycophenolate Sodium
mycophenolic acid
mycophenolic acid
mycophenolic acid

---
http://www.has-sante.fr/portail/jcms/c_2620141/fr/kengrexal
2016
false
false
false
France
French
treatment outcome
cangrelor
cangrelor
drug therapy, combination
adult
coronary artery disease
percutaneous coronary intervention
injections, intravenous
infusions, intravenous
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
myocardial infarction
embolism and thrombosis
aspirin
hemorrhage
cangrelor
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
receptors, purinergic P2Y12
evaluation of the transparency committee
Cangrelor Tetrasodium
Cangrelor Tetrasodium
angioplasty
emergency treatment
adenosine monophosphate

---
http://www.has-sante.fr/portail/jcms/c_2621695/fr/raxone
2016
false
false
false
false
France
French
evaluation of the transparency committee
administration, oral
treatment outcome
idebenone
idebenone
insurance, health, reimbursement
optic atrophy, hereditary, leber
adult
adolescent
ubiquinone
ubiquinone
ubiquinone

---
Mise à disposition d’une nouvelle spécialité à base de fluorodopa
http://www.has-sante.fr/portail/jcms/c_2624087/fr/dopaview
2016
false
France
French
parkinson disease
parkinsonian disorders
neoplasms
fluorine radioisotopes
fluorodopa F 18
dihydroxyphenylalanine
Positron-Emission tomography
adult
injections, intravenous
fluorodopa (18f)
radiopharmaceuticals
evaluation of the transparency committee
parkinson disease
neoplasms
parkinsonian disorders

---
http://www.has-sante.fr/portail/jcms/c_2624078/fr/fluorochol
2016
false
false
false
France
French
evaluation of the transparency committee
radiopharmaceuticals
radiopharmaceuticals
fluoromethylcholine (18F)
injections, intravenous
neoplasm metastasis
prostatic neoplasms
carcinoma, hepatocellular
fluorocholine
fluorocholine
fluorine radioisotopes
fluorine radioisotopes
Positron-Emission tomography
neoplasm staging
choline
prostatic neoplasms
carcinoma, hepatocellular

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Pomalidomide-Imnovid-R-nouvelle-recommandation-importante-pour-le-depistage-du-virus-de-l-hepatite-B-avant-l-initiation-du-traitement-Lettre-aux-professionnels-de-sante
2016
false
false
false
France
French
guidelines for drug use
mass screening
hepatitis B
hepatitis B
pomalidomide
pomalidomide
Hepatitis B Screening
Reactivation of hepatitis B viral hepatitis (disorder)
pomalidomide
continuity of patient care
hepatitis b virus
multiple myeloma
thalidomide
thalidomide
thalidomide

---
http://www.has-sante.fr/portail/jcms/c_2625989/fr/somatuline-lp
2016
false
France
French
gastro-enteropancreatic neuroendocrine tumor
lanreotide acetate
lanreotide
injections
Delayed-Action preparations
peptides, cyclic
somatostatin
lanreotide
antineoplastic agents
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
intestinal neoplasms
pancreatic neoplasms
stomach neoplasms
neuroendocrine tumors

---
http://www.has-sante.fr/portail/jcms/c_2621468/fr/genvoya
http://www.has-sante.fr/portail/jcms/c_2621468/fr/genvoya-emtricitabine-cobicistat-elvitegravir-et-tenofovir-alafenamide-association-d-antiviraux
2016
false
false
false
France
French
treatment outcome
drug combinations
tenofovir alafenamide
elvitegravir
hiv infections
anti-hiv agents
adult
adolescent
human immunodeficiency virus i infection
administration, oral
HIV integrase inhibitors
reverse transcriptase inhibitors
emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
Cobicistat
Emtricitabine
evaluation of the transparency committee
guidelines for drug use
GS-7340
JTK 303
adenine
adenine
quinolones

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/1065/850
2016
false
false
false
Canada
French
drug administration schedule
critical appraisal or critical reading
Drug-Eluting stents
drug therapy, combination
multicenter studies as topic
thrombosis
aspirin
aspirin
Prasugrel Hydrochloride
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
thienopyridine
clopidogrel
platelet aggregation inhibitors
Drug-eluting coronary stent placement
hemorrhage
Coronary stent thrombosis
thienopyridine
stroke
myocardial infarction
time
platelet aggregation inhibitors
ticlopidine
ticlopidine
pyridines
pyridines

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Benfluorex-Mediator-bilan-du-suivi-de-pharmacovigilance-Point-d-Information
2016
false
false
false
France
French
pharmacovigilance
drug information
benfluorex
benfluorex
retrospective studies
pleural diseases
Pleural fibrosis
health surveys
population surveillance
fenfluramine
fenfluramine

---
http://www.has-sante.fr/portail/jcms/c_2613577/fr/fluorocholine-cis-bio-international
2016
false
false
false
France
French
evaluation of the transparency committee
radiopharmaceuticals
radiopharmaceuticals
fluoromethylcholine (18F)
injections, intravenous
neoplasm metastasis
prostatic neoplasms
fluorocholine
fluorocholine
fluorine radioisotopes
fluorine radioisotopes
outcome assessment (health care)
Positron-Emission tomography
neoplasm recurrence, local
neoplasm staging
choline
choline
choline
neoplasm recurrence, local
neoplasm metastasis

---
http://www.has-sante.fr/portail/jcms/c_2633680/fr/antiviraux-d-action-directe
2016
false
false
false
France
French
evaluation of the transparency committee
adult
hepatitis C, chronic
drug therapy, combination
Sofosbuvir
antiviral agents
direct acting antivirals
daclatasvir
Simeprevir
ledipasvir, sofosbuvir drug combination
dasabuvir
drug combinations
ombitasvir
ritonavir
paritaprevir
fibrosis, liver
risk
has patient
hepacivirus
infection
autoimmune diseases
hepatic fibrosis, nos
fibrosis
hepatitis C virus
human enterovirus 72
hepatitis C, chronic
business
liver cirrhosis
socialism
patients
chronic infectious disease
guideline
antiviral agents
chronic hepatitis, nos
health
case management
hepatitis c virus
hepatitis a virus
ABT-333
ABT-267
ABT-450
BMS-790052
fibrosis
commerce
patients
guideline
benzimidazoles
fluorenes
uridine monophosphate
sulfonamides
uracil
uracil
anilides
carbamates
macrocyclic compounds
imidazoles

---
http://www.has-sante.fr/portail/jcms/c_2637487/fr/caelyx-sarcome-de-kaposi
2016
false
false
false
France
French
evaluation of the transparency committee
antibiotics, antineoplastic
treatment outcome
infusions, intravenous
doxorubicin
liposomal doxorubicin
doxorubicin hydrochloride
hiv infections
AIDS-Related Kaposi Sarcoma
Tumor Progression
disease progression
sarcoma, kaposi
doxorubicin
polyethylene glycols
doxorubicin

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004059/human_med_001981.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
migalastat
drug approval
europe
treatment outcome
orphan drug production
young adult
adult
fabry disease
continuity of patient care
fabry disease
administration, oral
product surveillance, postmarketing
alpha-Galactosidase
adolescent
mutation
pregnancy
breast feeding
alpha-Galactosidase
drug evaluation, preclinical
migalastat
1-Deoxynojirimycin

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004094/human_med_001978.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Emtricitabine
drug combinations
drug approval
europe
treatment outcome
emtricitabine and tenofovir alafenamide
anti-hiv agents
anti-hiv agents
hiv infections
HIV-1
human immunodeficiency virus i infection
drug therapy, combination
administration, oral
reverse transcriptase inhibitors
reverse transcriptase inhibitors
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
adult
adolescent
emtricitabine tenofovir alafenamide
emtricitabine tenofovir alafenamide
Tenofovir
Emtricitabine
Tenofovir
adenine
Tenofovir

---
https://medicalforum.ch/fr/article/doi/fms.2016.02684/
2016
false
false
false
Switzerland
French
journal article
diabetes mellitus, type 2
dipeptidyl-peptidase iv inhibitors
practice guidelines as topic
glucagon-like peptide 1
GLP-1 Mimetics
GLP-1 Mimetics
dipeptidyl-peptidase iv inhibitors
cardiovascular diseases
obesity
Sodium-Glucose transporter 2
SGLT2 Inhibitor
SGLT2 Inhibitor
insulins
risk factors
weight loss
hypoglycemia
insulins
hypoglycemic agents

---
http://www.has-sante.fr/portail/jcms/c_2655920/fr/skudexum
2016
false
false
false
France
French
evaluation of the transparency committee
drug combinations
treatment outcome
insurance, health, reimbursement
dexketoprofen trometamol
dexketoprofen trometamol
tramadol hydrochloride
tramadol hydrochloride
administration, oral
analgesics, opioid
analgesics, opioid
anti-inflammatory agents, non-steroidal
anti-inflammatory agents, non-steroidal
acute pain
adult
tramadol and dexketoprofen
tramadol
tramadol
ketoprofen
ketoprofen
tromethamine
ketoprofen
tromethamine

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/1071
2016
false
false
false
Canada
French
journal article
chemoprevention
antiviral agents
valganciclovir
critical appraisal or critical reading
treatment outcome
risk factors
opportunistic infections
multicenter studies as topic
neutropenia
valganciclovir
antiviral agents
valganciclovir
continuity of patient care
cytomegalovirus infections
polymerase chain reaction
DNA, viral
hematopoietic stem cell transplantation
allografts
cytomegalovirus infections
ganciclovir
ganciclovir
ganciclovir

---
http://www.omedit-centre.fr/portail/gallery_files/site/136/2953/5062/5220.pdf
2016
false
false
false
France
French
pain
analgesics, opioid
administration, oral
guidelines for drug use
adult
dihydrocodeine
codeine
codeine

---
IASOglio 2 GBq/mL, solution injectable (code CIS : 64499306)
http://www.has-sante.fr/portail/jcms/c_2659628/fr/iasoglio
http://www.has-sante.fr/portail/jcms/c_2659628/fr/iasoglio-fluoroethyl-l-thyrosine-18f-ou-fet-radiopharmaceutique-a-usage-diagnostique-pour-detection-de-tumeurs
2016
false
false
false
France
French
evaluation of the transparency committee
diagnostic uses of chemicals
18F-fluoroethyl-L-tyrosine
Positron-Emission tomography
radiopharmaceuticals
glioma
injections, intravenous
guidelines for drug use
fluoroethyl-L-tyrosine (18F)
(18F)fluoroethyltyrosine
tyrosine
tyrosine
glioma

---
http://www.conseil-scientifique.public.lu/fr/publications/oncologie/sorafenib.html
http://www.conseil-scientifique.public.lu/content/dam/conseil_scientifique/publications/oncologie/sorafenib-2016.pdf
2016
false
false
true
Luxembourg
French
drug prescriptions
luxembourg
treatment outcome
survival analysis
sorafenib
thyroid carcinoma
carcinoma, hepatocellular
carcinoma, renal cell
raf kinases
antineoplastic agents
protein kinase inhibitors
receptors, vascular endothelial growth factor
receptor Protein-Tyrosine kinases
guidelines for drug use
neoplasm metastasis
Locally Advanced Malignant Neoplasm
Thyroid Gland Carcinoma
Differentiated Thyroid Gland Carcinoma
sorafenib
phenylurea compounds
niacinamide
thyroid neoplasms
niacinamide

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004057/human_med_002000.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drug combinations
dapagliflozin
dapagliflozin
saxagliptin and dapagliflozin
saxagliptin
saxagliptin
adult
diabetes mellitus, type 2
administration, oral
Sodium-Glucose transporter 2
incretins
incretins
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
glucosides
benzhydryl compounds
glucosides
benzhydryl compounds
dipeptides
adamantane
adamantane
dipeptides
adamantane

---
http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-10-fra.php#a22
2016
false
false
false
Canada
French
pharmacovigilance note
Reactivation of hepatitis B viral hepatitis (disorder)
pomalidomide
pomalidomide
pomalidomide
pomalidomide
thalidomide
thalidomide
thalidomide

---
FASLODEX (fulvestrant) - Risk of Unnecessary Therapy Modification due to Falsely Elevated Estradiol Levels
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2016/60590a-fra.php
2016
false
false
false
Canada
French
English
pharmacovigilance note
estradiol
breast neoplasms
antineoplastic agents, hormonal
breast neoplasms
menopause
radioimmunoassay
false positive reactions
fulvestrant
fulvestrant
estradiol

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/1109
2016
false
false
false
Canada
French
journal article
review of literature
adult
adolescent
child
treatment outcome
practice guidelines as topic
essential tremor
signs and symptoms
essential tremor
risk factors
propranolol
primidone
adrenergic beta-antagonists
topiramate
drug interactions
gabapentin
essential tremor
botulinum toxins, type A
essential tremor
fructose
fructose
amines
cyclohexanecarboxylic acids
gamma-aminobutyric acid

---
http://www.has-sante.fr/portail/jcms/c_2671828/fr/flucortac
2016
false
true
false
France
French
evaluation of the transparency committee
addison disease
administration, oral
treatment outcome
insurance, health, reimbursement
fludrocortisone
fludrocortisone acetate
adrenal insufficiency
fludrocortisone
fludrocortisone

---
http://www.has-sante.fr/portail/jcms/c_2676772/fr/dexpanthenol-eg-labo-conseil
2016
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
administration, cutaneous
ointments
dexpanthenol
infant
diaper rash
dermatologic agents
dermatitis, irritant
dexpanthenol
pantothenic acid

---
http://www.ansm.sante.fr/Activites/Autorisations-temporaires-d-utilisation-ATU/ATU-de-cohorte-en-cours/Liste-des-ATU-de-cohorte-en-cours/MIDOSTAURINE-25-mg-capsule-molle
2016
false
false
false
France
French
guidelines for drug use
summary of product characteristics
package leaflet
midostaurin
midostaurin
midostaurin
capsules
staurosporine
staurosporine
staurosporine

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Topiramate-Epitomax-et-ses-generiques-mise-en-garde-sur-l-utilisation-hors-AMM-dans-les-troubles-de-l-humeur-Lettre-aux-professionnels-de-sante
2016
false
false
false
France
French
Off-Label use
topiramate
topiramate
abnormalities, drug-induced
mood disorders
pharmacovigilance note
guidelines for drug use
topiramate
anticonvulsants
pregnancy
teratogens
fructose
fructose
fructose

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/L-ANSM-met-en-garde-contre-l-association-hors-AMM-d-hormone-de-croissance-avec-des-analogues-de-la-GnRH-ou-des-inhibiteurs-de-l-aromatase-chez-l-enfant-adolescent-Point-d-Information
2016
false
false
false
France
French
pharmacovigilance note
drug therapy, combination
Off-Label use
drug prescriptions
child
risk
aromatase inhibitors
gonadotropin-releasing hormone
growth hormone
puberty
adolescent
Long Term Adverse Effects
gonadotropin-releasing hormone

---
http://www.has-sante.fr/portail/jcms/c_2661383/fr/tygacil-tigecycline-glycylcyclines
http://www.has-sante.fr/portail/jcms/c_2661383/fr/tygacil
2016
false
France
French
English
evaluation of the transparency committee
antibiotic therapy
child
complicated intra-abdominal infections
Complicated infection
tigecycline
minocycline
anti-bacterial agents
infusions, intravenous
treatment outcome
tigecycline
soft tissue infections
skin diseases, infectious
soft tissue infections
skin diseases, infectious
tigecycline
clinical trials as topic
abdominal abscess
appendicitis
appendicitis
cholecystitis
cholecystitis
peptic ulcer perforation
intestinal perforation

---
http://www.has-sante.fr/portail/jcms/c_2661380/fr/baraclude-entecavir-antiviral-hepatite-b
http://www.has-sante.fr/portail/jcms/c_2661380/fr/baraclude
2016
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
child
adolescent
administration, oral
pharmaceutical solutions
tablets
treatment outcome
guanine
entecavir
insurance, health, reimbursement
hepatitis B, chronic
entecavir
antiviral agents

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004098/human_med_002025.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
eluxadoline
imidazoles
drug approval
europe
gastrointestinal agents
gastrointestinal agents
product surveillance, postmarketing
adult
irritable bowel syndrome
diarrhea
administration, oral
tablets
risk assessment
Irritable bowel syndrome with diarrhea (disorder)
aged
drug interactions
pregnancy
breast feeding
receptors, opioid, delta
receptors, opioid, mu
receptors, opioid, kappa
eluxadoline
eluxadoline
imidazoles
phenylalanine

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004125/human_med_002022.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
irinotecan
irinotecan
drug approval
europe
drug interactions
pregnancy
breast feeding
adult
neoplasm metastasis
pancreatic neoplasms
adenocarcinoma
Pancreatic adenocarcinoma
Metastatic Pancreatic Adenocarcinoma
antineoplastic combined chemotherapy protocols
risk assessment
antineoplastic agents, phytogenic
antineoplastic agents, phytogenic
infusions, intravenous
topoisomerase I inhibitors
topoisomerase I inhibitors
drug evaluation, preclinical
irinotecan
camptothecin

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Lenalidomide-Revlimid-R-nouvelles-recommandations-importantes-relatives-a-la-reactivation-virale-Lettre-aux-professionnels-de-sante
2016
false
false
false
France
French
guidelines for drug use
pharmacovigilance note
administration, oral
lenalidomide
lenalidomide
hepatitis b virus
herpesvirus 3, human
Reactivation of hepatitis B viral hepatitis (disorder)
virus activation
Infection reactivation
immunologic factors
herpes zoster
chickenpox
hepatitis B
continuity of patient care
Hepatitis B Screening
risk factors
thalidomide
thalidomide

---
http://www.has-sante.fr/portail/jcms/c_2680641/fr/cartrex
2016
false
France
French
treatment outcome
risk factors
aceclofenac
cardiovascular diseases
risk assessment
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
osteoarthritis
arthritis, rheumatoid
spondylitis, ankylosing
anti-inflammatory agents, non-steroidal
aceclofenac
diclofenac
aceclofenac

---
http://www.has-sante.fr/portail/jcms/c_2724031/fr/galafold
2016
false
false
false
France
French
evaluation of the transparency committee
administration, oral
treatment outcome
migalastat
migalastat
fabry disease
fabry disease
insurance, health, reimbursement
adult
adolescent
orphan drug production
1-Deoxynojirimycin
1-Deoxynojirimycin
1-Deoxynojirimycin

---
Summary Safety Review - Levetiracetam and Methotrexate - Assessing the Potential Risk of Drug-Drug Interaction
http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/levetiracetam-fra.php
2016
false
false
false
Canada
French
English
drug interactions
risk assessment
methotrexate
pharmacovigilance note
methotrexate
levetiracetam
levetiracetam
methotrexate
canada
renal insufficiency, acute
levetiracetam
methotrexate
methotrexate
product surveillance, postmarketing
etiracetam
etiracetam
acute kidney injury
piracetam
piracetam
piracetam

---
http://www.has-sante.fr/portail/jcms/c_2725868/fr/neofordex
https://www.has-sante.fr/portail/jcms/c_2725868/fr/neofordex-dexamethasone-glucocorticoide
2016
false
false
false
France
French
evaluation of the transparency committee
administration, oral
treatment outcome
dexamethasone acetate
dexamethasone acetate
dexamethasone
adult
antineoplastic combined chemotherapy protocols
multiple myeloma
glucocorticoids
glucocorticoids
guidelines for drug use
dexamethasone
dexamethasone
dexamethasone

---
Summary Safety Review - Incretin-Based Therapies - Assessing the Potential Risk of Pancreatic Cancer
http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/incretin-fra.php
2016
false
false
false
Canada
French
English
diabetes mellitus, type 2
pharmacovigilance note
incretins
pancreatic neoplasms
risk
exenatide
saxagliptin
alogliptin
hypoglycemic agents
Sitagliptin Phosphate
Liraglutide
drug evaluation
risk assessment
canada
peptides
venoms
adamantane
adamantane
dipeptides
piperidines
uracil
uracil

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/OTEZLA-aprelimast-nouvelles-recommandations-importantes-concernant-les-idees-et-comportements-suicidaires-Lettre-aux-professionnels-de-sante
2016
false
false
false
France
French
guidelines for drug use
administration, oral
risk assessment
apremilast
arthritis, psoriatic
psoriasis
continuity of patient care
adult
mental disorders
self-injurious behavior
product surveillance, postmarketing
pharmacovigilance note
apremilast
thalidomide
thalidomide

---
Direct-acting antivirals, used for hepatitis C, may reactivate hepatitis B
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2016/61274a-fra.php
2016
false
false
false
Canada
French
English
pharmacovigilance note
hepatitis C, chronic
adult
direct acting antivirals
antiviral agents
Hepatitis B reactivation
hepatitis B
risk assessment
product surveillance, postmarketing
canada
patient education handout
risk
daclatasvir
Sofosbuvir
Simeprevir
velpatasvir
ledipasvir
ledipasvir, sofosbuvir drug combination
dasabuvir
ritonavir
sofosbuvir-velpatasvir drug combination
BMS-790052
ABT-333
carbamates
Heterocyclic Compounds, 4 or More Rings
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
imidazoles
sulfonamides
uracil
uracil
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2728866/fr/reevaluation-des-antiviraux-d-action-directe-dans-le-traitement-de-l-hepatite-c
2016
false
false
false
France
French
guidelines for drug use
practice guideline
antiviral agents
hepatitis C, chronic
drug evaluation
Sofosbuvir
administration, oral
Simeprevir
direct acting antivirals
daclatasvir
ledipasvir
ledipasvir, sofosbuvir drug combination
drug therapy, combination
ritonavir
ombitasvir
paritaprevir
dasabuvir
drug resistance, viral
drug interactions
treatment outcome
BMS-790052
ABT-267
ABT-450
ABT-333
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
imidazoles
anilides
carbamates
macrocyclic compounds
sulfonamides
uracil
uracil

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Pas-d-argument-en-faveur-d-un-sur-risque-de-cancer-du-pancreas-associe-aux-incretinomimetiques-chez-les-patients-diabetiques-de-type-2-une-etude-de-l-ANSM-Point-d-Information
2016
false
false
false
France
French
drug evaluation
pancreatic neoplasms
diabetes mellitus, type 2
Incretin mimetic agent (substance)
dipeptidyl-peptidase iv inhibitors
hypoglycemic agents
glucagon-like peptide 1
risk assessment
europe
pancreatic neoplasms
risk
technical report
Glucagon-Like Peptide-1 Receptor

---
obeticholic acid
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004093/human_med_002043.jsp&mid=WC0b01ac058001d124
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00357
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
drug approval
europe
cholangitis
Primary cholangitis (disorder)
obeticholic acid
obeticholic acid
obeticholic acid
adult
drug therapy, combination
ursodeoxycholic acid
administration, oral
risk assessment
pregnancy
breast feeding
drug interactions
product surveillance, postmarketing
drug evaluation, preclinical
chenodeoxycholic acid
chenodeoxycholic acid
chenodeoxycholic acid

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003844/human_med_001998.jsp&mid=WC0b01ac058001d124
2016
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
ixazomib
ixazomib
ixazomib
drug approval
europe
orphan drug production
adult
multiple myeloma
antineoplastic combined chemotherapy protocols
antineoplastic agents
antineoplastic agents
administration, oral
proteasome inhibitors
proteasome inhibitors
risk assessment
product surveillance, postmarketing
drug monitoring
dexamethasone
lenalidomide
continuity of patient care
drug interactions
pregnancy
breast feeding
survival analysis
aged
drug evaluation, preclinical
boron compounds
glycine
glycine
boron compounds
glycine
thalidomide
thalidomide

---
http://www.has-sante.fr/portail/jcms/c_2732128/fr/odefsey
http://www.has-sante.fr/portail/jcms/c_2732128/fr/odefsey-emtricitabine-rilpivirine-tenofovir-alafenamide-association-d-antiretroviraux
2016
false
false
false
France
French
evaluation of the transparency committee
tenofovir alafenamide
tenofovir alafenamide
guidelines for drug use
administration, oral
treatment outcome
insurance, health, reimbursement
Emtricitabine, Rilpivirine, Tenofovir Drug Combination
Emtricitabine, Rilpivirine, Tenofovir Drug Combination
reverse transcriptase inhibitors
reverse transcriptase inhibitors
anti-hiv agents
anti-hiv agents
hiv infections
emtricitabine, tenofovir alafenamide and rilpivirine
adult
adolescent
human immunodeficiency virus i infection
HIV-1
GS-7340
GS-7340
adenine
adenine
adenine

---
http://www.has-sante.fr/portail/jcms/c_2735208/fr/xydalba
http://www.has-sante.fr/portail/jcms/c_2735208/fr/xydalba-dalbavancine-antibiotique-de-la-classe-des-glycopeptides
2016
false
false
false
France
French
evaluation of the transparency committee
adult
acute disease
skin diseases, bacterial
soft tissue infections
staphylococcal skin infections
methicillin resistance
Methicillin-Resistant staphylococcus aureus
infusions, intravenous
dalbavancin
dalbavancin
treatment outcome
dalbavancin
continuity of patient care
risk management
drug monitoring
anti-bacterial agents
anti-bacterial agents
guidelines for drug use
teicoplanin
teicoplanin
teicoplanin

---
http://www.riziv.fgov.be/SiteCollectionDocuments/consensus_litterature_resume_20161117.pdf
2016
false
false
false
Belgium
French
GLP-1 Mimetics
diabetes mellitus, type 2
review of literature
consensus
GLP-1 Mimetics
treatment outcome
albiglutide
albiglutide
Glucagon-like peptide-1 (GLP-1) analogues
drug therapy, combination
metformin
hypoglycemic agents
hypoglycemic agents
glimepiride
dulaglutide
dulaglutide
Liraglutide
Liraglutide
Sitagliptin Phosphate
sulfonylurea compounds
comparative effectiveness research
arterial pressure
exenatide
exenatide
insulin
pioglitazone
thyroid neoplasms
pancreatitis
Injection Site Reaction
cardiovascular diseases
practice guidelines as topic
Evidence-Based medicine
rGLP-1 protein
rGLP-1 protein
glucagon-like peptide 1
glucagon-like peptide 1
glucagon-like peptide 1
immunoglobulin fc fragments
recombinant fusion proteins
glucagon-like peptides
glucagon-like peptides
immunoglobulin fc fragments
recombinant fusion proteins
glucagon-like peptides
peptides
venoms
peptides
venoms
thiazolidinediones

---
http://pharmacomedicale.org/medicaments/par-specialites/item/analogues-pge1-misoprostol
2016
false
false
false
France
French
drug information
misoprostol
anti-ulcer agents
prostaglandins E
misoprostol
misoprostol
alprostadil

---
http://www.has-sante.fr/portail/jcms/c_2724031/fr/galafold-migalastat-molecule-chaperon-de-mutations-sensibles-de-l-galactosidase
2016
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
treatment outcome
migalastat
adult
alpha-Galactosidase
fabry disease
administration, oral
fabry disease
insurance, health, reimbursement
adolescent
orphan drug production
alpha-Galactosidase
Pharmacological Chaperone
molecular chaperones
migalastat
1-Deoxynojirimycin

---
http://lemedecinduquebec.org/archives/2016/12/exenatide-et-dulaglutide-traiter-le-diabete-une-fois-par-semaine/
2016
false
false
false
Canada
French
journal article
Glucagon-Like Peptide-1 Receptor
incretins
hypoglycemic agents
diabetes mellitus, type 2
drug therapy, combination
injections, subcutaneous
exenatide
dulaglutide
Once Weekly
drug interactions
treatment outcome
weight loss
recombinant fusion proteins
glucagon-like peptides
quebec
dulaglutide
exenatide
immunoglobulin fc fragments
peptides
venoms

---
https://www.revmed.ch/RMS/2016/RMS-N-527/Combinaison-gliptine-gliflozine-dans-le-traitement-du-diabete-de-type-2
2016
false
false
false
Switzerland
French
journal article
diabetes mellitus, type 2
drug combinations
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
SGLT2 Inhibitor
treatment outcome
saxagliptin and dapagliflozin
dapagliflozin
saxagliptin
Linagliptin
linagliptin and empagliflozin
empagliflozin
Empagliflozin + linagliptin (product)
administration, oral
Sodium-Glucose transporter 2
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
dipeptides
adamantane
adamantane
benzhydryl compounds
glucosides

---
http://www.has-sante.fr/portail/jcms/c_2617868/fr/migpriv
http://www.has-sante.fr/portail/jcms/c_952661/migpriv
2016
false
France
French
antimigraine preparations
treatment outcome
adult
migraine disorders
nausea
vomiting
drug combinations
aspirin
metoclopramide
administration, oral
lysine
acetylsalicylic acid lysinate
acetylsalicylic acid, combinations excl. psycholeptics
aspirin, metoclopramide drug combination
antiemetics
insurance, health, reimbursement
analgesics, non-narcotic
metoclopramide hydrochloride
evaluation of the transparency committee

---
http://www.inesss.qc.ca/activites/evaluation-des-medicaments/evaluation-des-medicaments/extrait-davis-au-ministre/cetrotide-3788.html
2016
false
Canada
French
English
evaluation of the transparency committee
ganirelix
gonadotropin-releasing hormone
hormone antagonists
ganirelix
cetrorelix
cetrorelix
hormone antagonists
cetrorelix
ganirelix
drug costs
treatment outcome
reproductive techniques, assisted
injections, subcutaneous
drug information

---
http://www.has-sante.fr/portail/jcms/c_2040111/fr/inspra
http://www.has-sante.fr/portail/jcms/c_1626105/fr/inspra
http://www.has-sante.fr/portail/jcms/c_973827/inspra
2015
false
France
French
heart failure
myocardial infarction
eplerenone
eplerenone
administration, oral
mineralocorticoid receptor antagonists
spironolactone
insurance, health, reimbursement
ventricular dysfunction, left
evaluation of the transparency committee
diuretics, potassium sparing

---
http://www.has-sante.fr/portail/jcms/c_2027362/fr/folinoral
http://www.has-sante.fr/portail/jcms/c_900475/folinoral
2015
false
France
French
pyrimethamine induced hematotoxicity
pyrimethamine induced hematotoxicity
toxic accident due to methotrexate
toxic accident due to methotrexate
methotrexate
trimethoprim
salazopyrine
pyrimethamine
leucovorin
administration, oral
calcium folinate
insurance, health, reimbursement
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
Leucovorin, Calcium (1:1) Salt
evaluation of the transparency committee
drug combinations
glucosamine
glucosamine
sulfasalazine

---
http://www.has-sante.fr/portail/jcms/c_2010713/fr/dectancyl
http://www.has-sante.fr/portail/jcms/c_724438/dectancyl
2015
false
France
French
corticosteroid therapy
evaluation of the transparency committee
administration, oral
dexamethasone acetate
dexamethasone
anti-inflammatory agents
dexamethasone
insurance, health, reimbursement

---
http://www.has-sante.fr/portail/jcms/c_2585432/fr/dermobacter
http://www.has-sante.fr/portail/jcms/c_987228/dermobacter
http://www.has-sante.fr/portail/jcms/c_400907/fr/dermobacter
2015
false
France
French
benzalkonium chloride
drug combinations
administration, cutaneous
insurance, health, reimbursement
benzalkonium compounds
anti-infective agents, local
chlorhexidine gluconate
chlorhexidine
chlorhexidine, combinations
treatment outcome
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2048973/fr/solupred
http://www.has-sante.fr/portail/jcms/c_977223/solupred
2015
false
France
French
treatment outcome
adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
administration, oral
prednisolone 21-3-sulfobenzoate
prednisone
glucocorticoids
prednisolone
insurance, health, reimbursement
anti-inflammatory agents
prednisolone
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2045299/fr/texodil
http://www.has-sante.fr/portail/jcms/c_1018492/texodil
2015
false
France
French
pharyngitis
exacerbation of chronic obstructive bronchitis
pulmonary disease, chronic obstructive
pulmonary disease, chronic obstructive
otitis media
maxillary sinusitis
antibiotic therapy
cefotiam hexetil
administration, oral
cefotiam
anti-bacterial agents
cefotiam
insurance, health, reimbursement
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2586912/fr/somatuline-lp
http://www.has-sante.fr/portail/jcms/c_1019676/somatuline-lp
2015
false
France
French
TSH Producing Pituitary Gland Adenoma
lanreotide
injections
Delayed-Action preparations
peptides, cyclic
somatostatin
lanreotide
acromegaly
antineoplastic agents
carcinoid tumor
treatment outcome
insurance, health, reimbursement
pituitary neoplasms
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2045306/fr/vitalipide-adultes
http://www.has-sante.fr/portail/jcms/c_951427/vitalipide
2015
false
France
French
vitamins
infusions, intravenous
dietary supplements
vitamin A
vitamins
ergocalciferols
drug combinations
alpha-Tocopherol
retinol palmitate
vitamin K 1
insurance, health, reimbursement
adult
adolescent
parenteral nutrition
alpha-Tocopherol Acetate
evaluation of the transparency committee

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004006/human_med_001810.jsp&mid=WC0b01ac058001d124
http://www.ema.europa.eu/ema/generateFeed/medicines/WC500173313
2015
false
Great Britain (UK)
English
French
drug evaluation
summary of product characteristics
package leaflet
Atherothrombosis prophylaxis
syndication feed
clopidogrel
clopidogrel
treatment outcome
drug approval
ticlopidine
platelet aggregation inhibitors
platelet aggregation inhibitors
drugs, generic
adult
atherosclerosis
myocardial infarction
ischemic attack, transient
peripheral vascular diseases
acute coronary syndrome
thrombosis
administration, oral
drug interactions
clopidogrel
aged
pregnancy
breast feeding
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
drug evaluation, preclinical

---
http://www.has-sante.fr/portail/jcms/c_2034331/fr/signifor
http://www.has-sante.fr/portail/jcms/c_2034331/fr/signifor-pasireotide-analogue-de-la-somatostatine
2015
false
France
French
evaluation of the transparency committee
acromegaly
guidelines for drug use
pasireotide
pasireotide
orphan drug production
pasireotide
adult
somatostatin
injections, intramuscular
aged
insurance, health, reimbursement
treatment outcome
risk management
product surveillance, postmarketing

---
http://www.cochrane.org/fr/CD008005
2015
false
France
French
french abstract
meta-analysis
phenylketonurias
treatment outcome
biopterin
sapropterin

---
Summary Basis of Decision (SBD) for Otezla
Apremilast, 10 mg, 20 mg, and 30 mg, tablets, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00238
2015
false
false
false
Canada
French
English
drug approval
canada
apremilast
apremilast
summary of product characteristics
administration, oral
phosphodiesterase 4 inhibitors
phosphodiesterase 4 inhibitors
adult
psoriasis
aged
pregnancy
breast feeding
drug evaluation
risk assessment
treatment outcome
anti-inflammatory agents, non-steroidal
anti-inflammatory agents, non-steroidal
antipsoriatics for systemic use
drug evaluation
thalidomide
thalidomide
thalidomide

---
http://www.has-sante.fr/portail/jcms/c_2008808/fr/javlor
2015
true
France
French
evaluation of the transparency committee
carcinoma, transitional cell
neoplasm metastasis
Vinflunine Ditartrate
Urothelial Carcinoma
Advanced Malignant Neoplasm
vinflunine
vinblastine
antineoplastic agents, phytogenic
infusions, intravenous
tubulin modulators
vinflunine
urinary bladder neoplasms
treatment outcome
vinflunine
antineoplastic agents, phytogenic
tubulin modulators

---
http://www.minerva-ebm.be/fr/article/1054
2015
false
false
false
minerva-ebm.be
Belgium
French
critical appraisal or critical reading
pulmonary disease, chronic obstructive
drug therapy, combination
treatment outcome
indacaterol
glycopyrrolate
muscarinic antagonists
bronchodilator agents
QVA149
Tiotropium Bromide
indans
quinolones
glycopyrrolate

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003746/human_med_001835.jsp&mid=WC0b01ac058001d124
2015
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
apremilast
apremilast
apremilast
drug approval
europe
adult
psoriasis
arthritis, psoriatic
phosphodiesterase 4 inhibitors
phosphodiesterase 4 inhibitors
administration, oral
anti-inflammatory agents, non-steroidal
anti-inflammatory agents, non-steroidal
risk management
drug monitoring
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
aged
clinical trials as topic
drug evaluation, preclinical
thalidomide
thalidomide
thalidomide

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003837/human_med_001833.jsp&mid=WC0b01ac058001d124
2015
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
sulfonamides
sulfonamides
antiviral agents
antiviral agents
drug approval
europe
uracil
adult
hepatitis C, chronic
drug therapy, combination
administration, oral
enzyme inhibitors
enzyme inhibitors
NS-5b protein, hepatitis C virus
NS-5 protein, hepatitis C virus
drug monitoring
product surveillance, postmarketing
risk management
drug interactions
pregnancy
breast feeding
drug resistance, viral
clinical trials as topic
drug evaluation, preclinical
dasabuvir
dasabuvir
dasabuvir
viral nonstructural proteins
ABT-333
ABT-333

---
http://www.has-sante.fr/portail/jcms/c_2014032/fr/iasocholine
2015
false
false
false
France
French
evaluation of the transparency committee
injections, intravenous
radiopharmaceuticals
fluorocholine
fluorine radioisotopes
fluoromethylcholine (18F)
prostatic neoplasms
carcinoma, hepatocellular
bone neoplasms
bone neoplasms
neoplasm metastasis
Positron-Emission tomography
choline
choline
carcinoma, hepatocellular
neoplasm metastasis
bone neoplasms

---
http://www.has-sante.fr/portail/jcms/c_2015058/fr/quelle-place-pour-les-benzodiazepines-dans-linsomnie-fiche-bum
2015
false
true
false
France
French
guidelines for drug use
sleep initiation and maintenance disorders
benzodiazepines
hypnotics and sedatives
benzodiazepines
hypnotics and sedatives
adult
aged
Duration of treatment (qualifier value)
time factors
lormetazepam
benzodiazepine derivatives
estazolam
nitrazepam
triazulenone
zolpidem
zopiclone
temazepam
withdrawing treatment
therapy cessation
lorazepam
lorazepam
pyridines
piperazines
azabicyclo compounds

---
http://www.minerva-ebm.be/fr/article/1064
2015
false
false
false
minerva-ebm.be
Belgium
French
Dutch
critical appraisal or critical reading
alcoholism
meta-analysis as topic
adult
acamprosate
harm reduction
naltrexone
drugs used in alcohol dependence
topiramate
nalmefene
treatment outcome
alcohol drinking
secondary prevention
taurine
taurine
fructose
fructose
naltrexone

---
http://www.has-sante.fr/portail/jcms/c_2025737/fr/exviera/viekirax
http://www.has-sante.fr/portail/jcms/c_2025737/fr/viekirax-ombitasvir/paritaprevir/ritonavir-association-fixe-dantiviraux-a-action-directe-exviera-dasabuvir-antiviral-a-action-directe
2015
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
drug combinations
administration, oral
hepatitis C, chronic
drug therapy, combination
adult
anilides
anilides
carbamates
carbamates
antiviral agents
antiviral agents
macrocyclic compounds
macrocyclic compounds
ritonavir
ritonavir
sulfonamides
sulfonamides
uracil
treatment outcome
insurance, health, reimbursement
Hepatitis C virus genotype 1 (organism)
Hepatitis C virus genotype 4 (organism)
ombitasvir
ABT-450
dasabuvir
dasabuvir
daclatasvir
simeprevir
ombitasvir, paritaprevir and ritonavir
paritaprevir
ABT-267
ABT-333

---
http://www.has-sante.fr/portail/jcms/c_2022100/fr/harvoni
http://www.has-sante.fr/portail/jcms/c_2022100/fr/harvoni-sofosbuvir/ledipasvir-association-fixe-dantiviraux-a-action-directe
2015
false
false
false
France
French
evaluation of the transparency committee
administration, oral
treatment outcome
drug combinations
benzimidazoles
benzimidazoles
fluorenes
fluorenes
antiviral agents
antiviral agents
hepatitis C, chronic
adult
guidelines for drug use
Hepatitis C virus genotype 1 (organism)
Hepatitis C virus genotype 3 (organism)
Hepatitis C virus genotype 4 (organism)
insurance, health, reimbursement
ledipasvir
ledipasvir
sofosbuvir and ledipasvir
Sofosbuvir
Sofosbuvir
ledipasvir, sofosbuvir drug combination
ledipasvir, sofosbuvir drug combination
uridine monophosphate
uridine monophosphate
uridine monophosphate

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Pomalidomide-Imnovid-R-nouvelles-recommandations-importantes-de-minimisation-des-risques-Lettre-aux-profesionnels-de-sante
2015
false
false
false
France
French
pomalidomide
multiple myeloma
pharmacovigilance note
guidelines for drug use
administration, oral
Chemical and Drug Induced Liver Injury
heart failure
lung diseases, interstitial
pomalidomide
risk
risk factors
continuity of patient care
pharmacovigilance
Cardiotoxicity
thalidomide
thalidomide

---
http://ansm.sante.fr/S-informer/Travaux-de-l-Agence-Europeenne-des-Medicaments-EMA-Comite-des-medicaments-a-usage-humain-CHMP/Traitement-de-l-hepatite-C-l-ANSM-et-l-EMA-recommandent-d-eviter-l-association-entre-des-antiviraux-d-action-directe-et-l-amiodarone-Point-d-Information
2015
false
false
false
France
French
guidelines for drug use
pharmacovigilance note
hepatitis C
amiodarone
drug interactions
antiviral agents
bradycardia
cardiac conduction defect
benzimidazoles
fluorenes
ledipasvir
drug combinations
drug therapy, combination
arrhythmias, cardiac
continuity of patient care
drug monitoring
daclatasvir
Cardiotoxicity
Sofosbuvir
ledipasvir
ledipasvir, sofosbuvir drug combination
BMS-790052
heart conduction system
imidazoles
uridine monophosphate
uridine monophosphate

---
http://www.has-sante.fr/portail/jcms/c_2021610/fr/interruption-medicamenteuse-de-grossesse-les-protocoles-a-respecter
2015
false
true
false
France
French
guidelines for drug use
abortion, Drug-Induced
abortion, induced
drug therapy, combination
mifepristone
abortifacient agents, steroidal
hormone antagonists
administration, oral
administration, intravaginal
gemeprost
gemeprost
mifepristone
misoprostol
misoprostol
treatment outcome
abortifacient agents, nonsteroidal
drug prescriptions
abortion, induced
alprostadil
alprostadil

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Risque-d-arythmies-avec-Harvoni-ou-Sovaldi-en-association-avec-Daklinza-lors-de-la-co-administration-avec-l-amiodarone-Lettre-aux-professionnels-de-sante
2015
false
false
false
France
French
guidelines for drug use
pharmacovigilance note
hepatitis C
amiodarone
drug interactions
antiviral agents
bradycardia
cardiac conduction defect
benzimidazoles
fluorenes
ledipasvir
drug combinations
drug therapy, combination
arrhythmias, cardiac
continuity of patient care
drug monitoring
daclatasvir
Cardiotoxicity
Sofosbuvir
ledipasvir
ledipasvir, sofosbuvir drug combination
BMS-790052
imidazoles
heart conduction system
heart conduction system
uridine monophosphate
uridine monophosphate

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002780/human_med_001837.jsp&mid=WC0b01ac058001d124
http://www.ema.europa.eu/ema/generateFeed/medicines/WC500177372
2015
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
ospemifene
ospemifene
ospemifene
drug approval
europe
postmenopause
administration, oral
dyspareunia
vulvar diseases
vaginal diseases
vulvovaginal dryness
selective estrogen receptor modulators
selective estrogen receptor modulators
atrophy
product surveillance, postmarketing
drug interactions
breast feeding
drug evaluation, preclinical
tamoxifen
tamoxifen
tamoxifen

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002396/human_med_001847.jsp&mid=WC0b01ac058001d124
http://www.ema.europa.eu/ema/generateFeed/medicines/WC500179029
2015
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
safinamide
safinamide
drug therapy, combination
levodopa
parkinson disease
On - off phenomenon (disorder)
administration, oral
product surveillance, postmarketing
safinamide methanesulfonate
safinamide methanesulfonate
antiparkinson agents
antiparkinson agents
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
monoamine oxidase inhibitors
monoamine oxidase inhibitors
reversible inhibitors of monoamine oxidase
monoamine oxidase B
safinamide
monoamine oxidase
monoamine oxidase inhibitors
alanine
alanine
benzylamines
alanine
benzylamines

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002840/human_med_001848.jsp&mid=WC0b01ac058001d124
http://www.ema.europa.eu/ema/generateFeed/medicines/WC500179030
2015
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
dalbavancin
dalbavancin
dalbavancin
drug approval
europe
anti-bacterial agents
anti-bacterial agents
adult
soft tissue infections
skin diseases, bacterial
acute disease
cellulitis
abscess
wound infection
infusions, intravenous
Methicillin resistant Staphylococcus aureus infection (disorder)
Methicillin-Resistant staphylococcus aureus
staphylococcal skin infections
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
antibiotic therapy
teicoplanin
teicoplanin
teicoplanin

---
http://www.has-sante.fr/portail/jcms/c_2022075/fr/xtandi-enzalutamide-inhibiteur-de-la-voie-de-signalisation-des-recepteurs-aux-androgenes
http://www.has-sante.fr/portail/jcms/c_2022075/fr/xtandi
2015
false
false
false
France
French
guidelines for drug use
evaluation of the transparency committee
administration, oral
treatment outcome
enzalutamide
enzalutamide
antineoplastic agents, hormonal
antineoplastic agents, hormonal
prostatic neoplasms, Castration-Resistant
neoplasm metastasis
enzalutamide
survival analysis
insurance, health, reimbursement
androgen antagonists
androgen antagonists
MDV 3100
MDV 3100
phenylthiohydantoin
phenylthiohydantoin
phenylthiohydantoin

---
http://www.has-sante.fr/portail/jcms/c_2030395/fr/levidcen
2015
false
false
false
France
French
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
levetiracetam
levetiracetam
Oral form levetiracetam (product)
anticonvulsants
treatment outcome
epilepsies, partial
adult
adolescent
drug therapy, combination
child
infant
myoclonic epilepsy, juvenile
epilepsies, myoclonic
seizures, Tonic-Clonic
epilepsy, idiopathic generalized
Granule Dosage Form
seizures
etiracetam
piracetam
piracetam
epilepsy, generalized

---
http://www.has-sante.fr/portail/jcms/c_2014032/fr/iasocholine-chlorure-de-fluorocholine-18f-radiopharmaceutique-a-usage-diagnostique
2015
false
false
false
France
French
guidelines for drug use
evaluation of the transparency committee
radiopharmaceuticals
radiopharmaceuticals
fluoromethylcholine (18F)
injections, intravenous
neoplasm metastasis
prostatic neoplasms
Metastatic Malignant Neoplasm to the Bone
carcinoma, hepatocellular
fluorocholine
fluorocholine
fluorine radioisotopes
fluorine radioisotopes
outcome assessment (health care)
Positron-Emission tomography
bone neoplasms
choline
choline
choline
neoplasm metastasis
carcinoma, hepatocellular

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Renforcement-des-conditions-de-prescription-et-de-delivrance-des-specialites-a-base-de-Valproate-et-derives-Depakine-R-Depakote-R-Depamide-R-Micropakine-R-et-generiques-du-fait-des-risques-lies-a-leur-utilisation-pendant-la-grossesse-Point-d-information
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Nouvelles-conditions-de-prescription-et-de-delivrance-des-specialites-a-base-de-valproate-et-derives-Depakine-R-Depakote-R-Depamide-R-Micropakine-R-et-generiques-du-fait-des-risques-lies-a-leur-utilisation-pendant-la-grossesse-Lettre-aux-professionnels-de-sante
2015
false
false
false
France
French
Divalproex Sodium
pregnancy
pharmacovigilance note
valproate sodium
valproic acid
valpromide
dipropylacetamide
risk assessment
drug evaluation
anticonvulsants
abnormalities, drug-induced
prenatal exposure delayed effects
continuity of patient care
contraception
adult
adolescent
women
maternal exposure
guidelines for drug use
legislation, pharmacy
patient education handout
-
valproic acid
valproic acid

---
Summary Safety Review - NEXAVAR (sorafenib) - Thyroid Gland Dysfunction
http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/nexavar-fra.php
2015
false
false
false
Canada
French
English
pharmacovigilance note
sorafenib
sorafenib
thyroid diseases
antineoplastic agents
risk
thyroid crisis
protein kinase inhibitors
drug monitoring
continuity of patient care
niacinamide
niacinamide
phenylurea compounds

---
http://www.minerva-ebm.be/fr/article/1092
2015
false
false
false
minerva-ebm.be
Belgium
French
Dutch
critical appraisal or critical reading
platelet aggregation inhibitors
drug therapy, combination
aspirin
administration, oral
clopidogrel
risk assessment
cardiovascular diseases
cardiovascular diseases
Long-Term care
treatment outcome
meta-analysis as topic
Prasugrel Hydrochloride
ticlopidine
ticlopidine

---
http://www.has-sante.fr/portail/jcms/c_2024183/fr/ferinject
2015
false
France
French
iron, parenteral preparations
iron
deficiency diseases
iron deficiency, nos
treatment outcome
ferric carboxymaltose
maltose
ferric compounds
infusions, intravenous
evaluation of the transparency committee

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Saxagliptine-Onglyza-et-Komboglyze-analyses-complementaires-sur-le-risque-de-mortalite-par-infection-donnees-de-l-etude-SAVOR-Point-d-Information
2015
false
false
false
France
French
risk assessment
drug evaluation
saxagliptin
saxagliptin
metformin and saxagliptin
pharmacovigilance note
drug combinations
dipeptidyl-peptidase iv inhibitors
metformin
diabetes mellitus, type 2
infection
mortality
cause of death
adamantane
adamantane
dipeptides

---
http://www.cfp.ca/content/61/6/e266?etoc
2015
false
false
false
Canada
French
alcohol-related disorders
alcohol drinking
journal article
case reports
counseling
alcohol-related disorders
naltrexone
disulfiram
acamprosate
alcohol deterrents
narcotic antagonists
alcohol-related disorders
general practice
general practitioners
taurine
taurine

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Mycophenolate-Cellcept-R-et-generiques-et-Myfortic-R-risque-d-avortements-spontanes-et-de-malformations-en-cas-d-exposition-pendant-la-grossesse-Point-d-Information
2015
false
false
false
France
French
pregnancy
pharmacovigilance note
abnormalities, drug-induced
immunosuppressive agents
ear
risk
teratogens
abortion, spontaneous
infant, newborn
mycophenolic acid
mycophenolic acid

---
http://ansm.sante.fr/Activites/Autorisations-temporaires-d-utilisation-ATU/ATU-de-cohorte-en-cours/Liste-des-ATU-de-cohorte-en-cours/LUTATHERA-370-MBq-mL-solution-pour-perfusion
2015
false
false
false
France
French
neuroendocrine tumors
summary of product characteristics
package leaflet
guidelines for drug use
intestinal neoplasms
radiopharmaceuticals
radiopharmaceuticals
neoplasm metastasis
(177lutetium-DOTA(O)Tyr3)octreotate
(177lutetium-DOTA(O)Tyr3)octreotate
lutetium
drug compounding
adult
drug evaluation
risk assessment
infusions, intravenous
treatment outcome
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003773/human_med_001852.jsp&mid=WC0b01ac058001d124
2015
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
cangrelor
cangrelor
cangrelor
drug therapy, combination
adult
coronary artery disease
percutaneous coronary intervention
injections, intravenous
infusions, intravenous
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
platelet aggregation inhibitors
myocardial infarction
embolism and thrombosis
product surveillance, postmarketing
aspirin
hemorrhage
cangrelor
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
drug interactions
pregnancy
breast feeding
receptors, purinergic P2Y12
drug evaluation, preclinical
adenosine monophosphate

---
http://www.has-sante.fr/portail/jcms/c_2044336/fr/nexavar
http://www.has-sante.fr/portail/jcms/c_2044336/fr/nexavar-sorafenib-inhibiteur-de-proteine-kinase
2015
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
insurance, health, reimbursement
treatment outcome
administration, oral
sorafenib
sorafenib
sorafenib tosylate
sorafenib tosylate
sorafenib
protein kinase inhibitors
protein kinase inhibitors
survival analysis
neoplasm metastasis
thyroid carcinoma
quality of life
thyroid neoplasms
phenylurea compounds
niacinamide
niacinamide
phenylurea compounds
niacinamide

---
http://www.has-sante.fr/portail/jcms/c_2040751/fr/daivobet
2015
true
France
French
scalp psoriasis
betamethasone dipropionate, calcipotriol drug combination
administration, topical
drug combinations
psoriasis
calcipotriol, combinations
calcipotriene
betamethasone
calcitriol
betamethasone-17,21-dipropionate
insurance, health, reimbursement
scalp dermatoses
administration, cutaneous
adult
treatment outcome
gels
evaluation of the transparency committee
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2048970/fr/keppra
2015
false
France
French
evaluation of the transparency committee
levetiracetam
etiracetam
piracetam
administration, oral
insurance, health, reimbursement
anticonvulsants
infant
child
adult
epilepsies, partial
drug therapy, combination
myoclonic epilepsy, juvenile
epilepsy, idiopathic generalized
epilepsy
levetiracetam
epilepsy, generalized

---
Gluconorm (repaglinide) - New Contraindication for Concomitant Use with Clopidogrel
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2015/54454a-fra.php
2015
false
false
false
Canada
French
English
drug interactions
repaglinide
repaglinide
clopidogrel
clopidogrel
diabetes mellitus, type 2
hypoglycemic agents
purinergic P2Y receptor antagonists
platelet aggregation inhibitors
hypoglycemia
pharmacovigilance note
Cytochrome P-450 CYP2C8 Inhibitors
carbamates
piperidines
ticlopidine
ticlopidine

---
http://www.anocef.org/download.php?modele=anocef_recommandations_ther-sys_2015
http://anocef.org/download.php?modele=anocef_recommandations_ther-sys_2015
2015
false
false
false
France
French
practice guideline
guidelines for drug use
antineoplastic combined chemotherapy protocols
antineoplastic agents
administration, oral
infusions, intravenous
antineoplastic agents
Drug-Related side effects and adverse reactions
temozolomide
lomustine
Lomustine/Procarbazine/Vincristine
vincristine
procarbazine
fotemustine
carboplatin
Carboplatin/Etoposide
etoposide
brain neoplasms
Drug Extravasation
continuity of patient care
drug monitoring
chemotherapy-induced nausea and vomiting
antiemetics
thrombocytopenia
Chemotherapy-Induced febrile neutropenia
kidney diseases
hypertension
Bevacizumab
dacarbazine
dacarbazine
nitrosourea compounds
organophosphorus compounds

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/DUOPLAVIN-75mg-clopidogrel-75-mg-acide-acetylsalicylqiue-rappel-des-principales-informations-de-l-AMM-relatives-a-ses-indications-et-a-sa-posologie-Lettre-aux-professionnels-de-sante
2015
false
false
false
France
French
guidelines for drug use
drug combinations
administration, oral
aspirin
aspirin
clopidogrel
clopidogrel
clopidogrel bisulfate
clopidogrel bisulfate
platelet aggregation inhibitors excl. heparin combinations
drug utilization review
platelet aggregation inhibitors
platelet aggregation inhibitors
Off-Label use
myocardial infarction
acute coronary syndrome
ticlopidine
ticlopidine
ticlopidine

---
http://www.e-cancer.fr/content/download/126023/1524677/file/Médicaments%20immunomodulateurs%20(imid).pdf
2015
false
false
false
France
French
guidelines for drug use
administration, oral
lenalidomide
pomalidomide
lenalidomide
pomalidomide
thalidomide
thalidomide
thalidomide
antineoplastic agents
immunologic factors
continuity of patient care
information dissemination
hospital-physician relations
physician-patient relations
teratogens
contraception
pregnancy
drug interactions
practice guideline
Drug-Related side effects and adverse reactions

---
http://www.omeditbretagne.fr/lrportal/documents/138946/147512/imnovid-v1-3pro.pdf/06e6f024-dd6b-46ce-ab5c-fd094567d23e
2015
false
false
false
France
French
guidelines for drug use
pomalidomide
pomalidomide
administration, oral
continuity of patient care
Drug-Related side effects and adverse reactions
drug interactions
adult
multiple myeloma
immunomodulators
immunomodulators
neoplasm recurrence, local
pomalidomide
pomalidomide
thalidomide
immunologic factors
immunologic factors

---
http://www.omeditbretagne.fr/lrportal/documents/138946/147512/NEXAVAR+V1_6pro.pdf/ee0e68ba-3a95-476d-bae2-29d81088d6ac
2015
false
false
false
France
French
guidelines for drug use
sorafenib
sorafenib
administration, oral
drug interactions
continuity of patient care
Drug-Related side effects and adverse reactions
sorafenib tosylate
sorafenib tosylate
antineoplastic agents
antineoplastic agents
protein kinase inhibitors
protein kinase inhibitors
carcinoma, hepatocellular
carcinoma, renal cell
thyroid carcinoma
sorafenib
phenylurea compounds
niacinamide
thyroid neoplasms
phenylurea compounds
niacinamide
niacinamide
phenylurea compounds
niacinamide

---
http://www.omeditbretagne.fr/lrportal/documents/138946/147512/revlimid-v1_8pro.pdf/00560e9e-481b-4202-b3e0-22dfab8b8762
2015
false
false
false
France
French
guidelines for drug use
lenalidomide
lenalidomide
administration, oral
continuity of patient care
drug interactions
Drug-Related side effects and adverse reactions
adult
multiple myeloma
immunologic factors
immunologic factors
antineoplastic agents
antineoplastic agents
Chromosome 5q Deletion Syndrome
Myelodysplastic Syndrome with Isolated del(5q)
teratogens
contraception
lenalidomide
thalidomide
anemia, macrocytic
chromosome deletion
chromosomes, human, pair 5

---
http://www.bordet.be./fr/services/servmed/nucleair/therapie/images/Instructions%20de%20Radioprotection%20H-E%20fr.doc
2015
false
true
false
Belgium
French
popular works
177Lu-octreotate
brachytherapy
radiation protection
octreotide
octreotide

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003834/human_med_001900.jsp&mid=WC0b01ac058001d124
2015
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
idebenone
idebenone
idebenone
drug approval
europe
adult
adolescent
orphan drug production
optic atrophy, hereditary, leber
administration, oral
vision disorders
antioxidants
antioxidants
Idebenone (product)
product surveillance, postmarketing
drug monitoring
pregnancy
breast feeding
drug interactions
ubiquinone
ubiquinone
ubiquinone

---
http://www.has-sante.fr/portail/jcms/c_2569101/fr/variquel
2015
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
terlipressin
terlipressin
Terlipressin Acetate
Esophageal Varices Hemorrhage
esophageal and gastric varices
gastrointestinal hemorrhage
emergency treatment
vasoconstrictor agents
vasoconstrictor agents
terlipressin
injections, intravenous
lypressin
lypressin
lypressin

---
http://www.has-sante.fr/portail/jcms/c_2569071/fr/xadago
http://www.has-sante.fr/portail/jcms/c_2569071/fr/xadago-safinamide-antiparkinsonien
2015
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
safinamide methanesulfonate
safinamide methanesulfonate
administration, oral
adult
drug therapy, combination
parkinson disease
monoamine oxidase inhibitors
monoamine oxidase inhibitors
guidelines for drug use
Motor fluctuations
safinamide
safinamide
safinamide
benzylamines
alanine
alanine
benzylamines
alanine

---
http://www.jle.com/fr/revues/ito/e-docs/les_nouveaux_agents_du_myelome._quels_impacts_sur_les_strategies_therapeutiques__305647/article.phtml
10.1684/ito.2015.0001
2015
false
false
false
France
French
journal article
multiple myeloma
antineoplastic combined chemotherapy protocols
proteasome inhibitors
carfilzomib
Ixazomib
pomalidomide
immunologic factors
antibodies, monoclonal
daratumumab
clinical trials as topic
treatment outcome
antibodies, monoclonal, humanized
elotuzumab
histone deacetylase inhibitors
CD38 protein, human
disease-free survival
SLAMF7 protein, human
panobinostat
indoles
hydroxamic acids
oligopeptides
thalidomide
thalidomide
membrane glycoproteins
antigens, cd38
receptors, immunologic

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/1010
2015
false
false
false
Canada
French
drug combinations
administration, inhalation
QVA149
indacaterol
critical appraisal or critical reading
glycopyrrolate
cholinergic antagonists
adrenergic beta-2 receptor agonists
pulmonary disease, chronic obstructive
bronchodilator agents
treatment outcome
multicenter studies as topic
COPD exacerbation
disease exacerbation
indacaterol and glycopyrronium bromide
quality of life
disease progression
indans
quinolones
glycopyrrolate

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Mycophenolate-Cellcept-R-et-generiques-et-Myfortic-R-nouvelles-contre-indications-et-mesures-de-prevention-de-la-grossesse-en-raison-du-risque-important-de-teratogenicite-point-d-Information
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Mycophenolate-mofetil-Cellcept-ses-generiques-et-Mycophenolate-sodique-Myfortic-nouvelles-contre-indications-et-mesures-de-prevention-de-la-grossesse-en-raison-du-risque-de-teratogenicite-Lettre-aux-professionnels-de-sante
2015
false
false
false
France
French
pharmacovigilance note
pregnancy
mycophenolic acid
guidelines for drug use
Mycophenolate Sodium
graft rejection
Mycophenolate Sodium
immunosuppressive agents
immunosuppressive agents
teratogens
abnormalities, drug-induced
abortion, spontaneous
contraception
mycophenolic acid
mycophenolic acid
mycophenolic acid

---
http://www.has-sante.fr/portail/jcms/c_2572469/fr/cetornan
http://www.has-sante.fr/portail/jcms/c_2572469/fr/cetornan-5-g-ornithine-therapeutique-hepatique
http://www.has-sante.fr/portail/jcms/c_939180/cetornan
http://www.has-sante.fr/portail/jcms/c_400298/fr/cetornan-5-g-poudre-pour-solution-buvable-et-solution-enterale-en-sachet-10-sachet-s-papier-aluminium-polyethylene-de-5-g-code-cip-330-278-2
2015
false
false
false
false
France
French
evaluation of the transparency committee
ornithine alpha-ketoglutarate
guidelines for drug use
drugs, generic
aged
administration, oral
enteral nutrition
malnutrition
treatment outcome
insurance, health, reimbursement
ornithine
ornithine

---
Case report: International case of respiratory depression in a child with ultrarapid CYP2D6 metabolism after tramadol use
http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2015-11-fra.php#e
2015
false
false
false
Canada
French
English
journal article
case reports
tramadol
child
respiratory insufficiency
respiratory depression
pain, postoperative
CYP2D6 ultrarapid metaboliser status
cytochrome p-450 cyp2d6
administration, oral
analgesics, opioid
tramadol
analgesics, opioid
O-demethyltramadol
tramadol
tramadol

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004042/human_med_001940.jsp&mid=WC0b01ac058001d124
2015
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug approval
europe
tenofovir alafenamide
tenofovir alafenamide
elvitegravir
elvitegravir
hiv infections
drug interactions
pregnancy
breast feeding
product surveillance, postmarketing
drug evaluation, preclinical
anti-hiv agents
anti-hiv agents
adult
adolescent
human immunodeficiency virus i infection
administration, oral
Integrase strand transfer inhibitor (substance)
HIV integrase inhibitors
HIV integrase inhibitors
Cytochrome P-450 CYP3A Inhibitors
Cytochrome P-450 CYP3A Inhibitors
reverse transcriptase inhibitors
reverse transcriptase inhibitors
emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
Cobicistat
Cobicistat
Emtricitabine
Emtricitabine
GS-7340
GS-7340
JTK 303
JTK 303
adenine
adenine
adenine
quinolones
quinolones

---
https://www.has-sante.fr/portail/jcms/c_2579446/fr/zontivity-vorapaxar-antiagregant-plaquettaire
2015
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
administration, oral
drug therapy, combination
vorapaxar
vorapaxar
vorapaxar
adult
myocardial infarction
platelet aggregation inhibitors
platelet aggregation inhibitors
aspirin
clopidogrel
Atherothrombosis
Atherothrombosis prophylaxis
atherosclerosis
thrombosis
Oral form vorapaxar (product)
lactones
pyridines
lactones
pyridines
ticlopidine
ticlopidine

---
http://www.has-sante.fr/portail/jcms/c_2579748/fr/alternatives-a-l-acide-valproique-chez-les-filles-adolescentes-femmes-en-age-de-procreer-et-femmes-enceintes-ayant-un-trouble-bipolaire-ou-une-epilepsie
2015
false
false
false
France
French
guidelines for drug use
valproic acid
antiepileptics
adolescent
adult
valproate sodium
anticonvulsants
epilepsy
teratogens
pregnancy
valproic acid antenatal infection
Divalproex Sodium
bipolar disorder
bipolar disorder
manic disorder
manic disorder
practice guideline
valproic acid
antipsychotic agents
antimanic agents
lithium compounds
lamotrigine
carbamazepine
levetiracetam
oxcarbazepine
antipsychotics
olanzapine
continuity of patient care
Aripiprazole
abnormalities, drug-induced
etiracetam
triazines
carbamazepine
benzodiazepines
piracetam
piracetam

---
http://www.has-sante.fr/portail/jcms/c_2579452/fr/cartrex
2015
false
France
French
treatment outcome
risk factors
aceclofenac
cardiovascular diseases
risk assessment
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
osteoarthritis
arthritis, rheumatoid
spondylitis, ankylosing
anti-inflammatory agents, non-steroidal
aceclofenac
diclofenac
aceclofenac

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003822/human_med_001939.jsp&mid=WC0b01ac058001d124
2015
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
orphan drug production
glycerol phenylbutyrate
glycerol phenylbutyrate
glycerol phenylbutyrate
urea cycle disorders, inborn
adult
adolescent
child
infant
carbamoyl-phosphate synthase i deficiency disease
ornithine carbamoyltransferase deficiency disease
argininosuccinic aciduria
hyperargininemia
citrullinemia
HHH syndrome
continuity of patient care
administration, oral
Enteral Route of Administration
product surveillance, postmarketing
Gastroenteral route (qualifier value)
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
ornithine
ornithine
hyperammonemia
phenylbutyrates
glycerol
glycerol
phenylbutyrates
glycerol

---
http://www.minerva-ebm.be/fr/article/2004
2015
false
false
false
Belgium
French
critical appraisal or critical reading
dermatitis, atopic
treatment outcome
infant
child
administration, topical
pimecrolimus
dermatologic agents
glucocorticoids
Topical Corticosteroid
adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
tacrolimus
tacrolimus

---
http://www.has-sante.fr/portail/jcms/c_2572175/fr/somavert
2015
false
France
French
insurance, health, reimbursement
injections, subcutaneous
pegvisomant
treatment outcome
pegvisomant
pegvisomant
human growth hormone
acromegaly
orphan drug production
receptors, somatotropin
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2585417/fr/auricularum
http://www.has-sante.fr/portail/jcms/c_400288/fr/auricularum
http://www.has-sante.fr/portail/jcms/c_2585417/fr/auricularum-oxytetracycline-polymyxine-b-dexamethasone-nystatine-association-fixe-d-antibiotiques-antimycosique-corticoide
2015
false
true
false
false
France
French
evaluation of the transparency committee
instillation, drug
dexamethasone and antiinfectives
auricularum
otitis externa
perioperative period
chronic disease
otitis
ear
perioperative care
treatment outcome
insurance, health, reimbursement
anti-inflammatory agents
glucocorticoids
anti-bacterial agents
antifungal agents
administration, topical
adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
antibiotic therapy
guidelines for drug use
nystatin
oxytetracycline
polymyxin B
dexamethasone
dexamethasone
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2585408/fr/otezla
http://www.has-sante.fr/portail/jcms/c_2585408/fr/otezla-apremilast-immunosuppresseur-inhibiteur-de-pde4
2015
false
false
false
false
France
French
evaluation of the transparency committee
administration, oral
apremilast
apremilast
apremilast
adult
arthritis, psoriatic
psoriasis
treatment outcome
insurance, health, reimbursement
aged
guidelines for drug use
phosphodiesterase 4 inhibitors
phosphodiesterase 4 inhibitors
thalidomide
thalidomide
thalidomide

---
http://www.has-sante.fr/portail/jcms/c_2586909/fr/kuvan
2015
false
false
false
France
French
evaluation of the transparency committee
administration, oral
infant, newborn
child
infant
treatment outcome
sapropterin
sapropterin
phenylketonurias
hyperphenylalaninaemia
orphan drug production
sapropterin
biopterin
biopterin
biopterin

---
E-mail
24/10/2017


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.